GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP3
|
ENSG00000172845.9 | Sp3 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SP3 | hg19_v2_chr2_-_174830430_174830563 | 0.53 | 1.7e-17 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_90015105 | 88.99 |
ENST00000567999.1
ENST00000566079.1 ENST00000566820.1 ENST00000562578.1 ENST00000561741.1 ENST00000268676.7 ENST00000562986.1 ENST00000569453.1 ENST00000567884.1 ENST00000569061.1 ENST00000418391.2 ENST00000561959.1 ENST00000567874.1 ENST00000570182.1 ENST00000563795.1 |
DEF8
|
differentially expressed in FDCP 8 homolog (mouse) |
chr6_-_4135693 | 83.40 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr6_-_4135825 | 74.11 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr19_-_55919087 | 73.71 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
chrX_-_152989798 | 66.07 |
ENST00000441714.1
ENST00000442093.1 ENST00000429550.1 ENST00000345046.6 |
BCAP31
|
B-cell receptor-associated protein 31 |
chr19_-_291365 | 65.09 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr19_-_291133 | 63.76 |
ENST00000327790.3
|
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr19_+_54694119 | 60.04 |
ENST00000456872.1
ENST00000302937.4 ENST00000429671.2 |
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
chr7_+_26241325 | 58.17 |
ENST00000456948.1
ENST00000409747.1 |
CBX3
|
chromobox homolog 3 |
chr11_+_65686952 | 57.52 |
ENST00000527119.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr10_+_120863587 | 57.39 |
ENST00000535029.1
ENST00000361432.2 ENST00000544016.1 |
FAM45A
|
family with sequence similarity 45, member A |
chr11_+_1968508 | 56.74 |
ENST00000397298.3
ENST00000381519.1 ENST00000397297.3 ENST00000381514.3 ENST00000397294.3 |
MRPL23
|
mitochondrial ribosomal protein L23 |
chr19_+_49497121 | 53.50 |
ENST00000413176.2
|
RUVBL2
|
RuvB-like AAA ATPase 2 |
chr20_+_32581452 | 53.35 |
ENST00000375114.3
ENST00000448364.1 |
RALY
|
RALY heterogeneous nuclear ribonucleoprotein |
chr7_+_26241310 | 53.23 |
ENST00000396386.2
|
CBX3
|
chromobox homolog 3 |
chr11_+_65687158 | 53.22 |
ENST00000532933.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr7_+_116139744 | 53.15 |
ENST00000343213.2
|
CAV2
|
caveolin 2 |
chr17_-_76183111 | 52.88 |
ENST00000405273.1
ENST00000590862.1 ENST00000590430.1 ENST00000586613.1 |
TK1
|
thymidine kinase 1, soluble |
chr1_-_8939265 | 52.16 |
ENST00000489867.1
|
ENO1
|
enolase 1, (alpha) |
chr11_-_535515 | 51.98 |
ENST00000311189.7
ENST00000451590.1 ENST00000417302.1 |
HRAS
|
Harvey rat sarcoma viral oncogene homolog |
chrX_+_118602363 | 51.64 |
ENST00000317881.8
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
chr2_-_10588630 | 51.02 |
ENST00000234111.4
|
ODC1
|
ornithine decarboxylase 1 |
chr11_-_2950642 | 50.95 |
ENST00000314222.4
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2 |
chr20_+_62371206 | 50.77 |
ENST00000266077.2
|
SLC2A4RG
|
SLC2A4 regulator |
chr17_-_79481666 | 50.37 |
ENST00000575659.1
|
ACTG1
|
actin, gamma 1 |
chr1_-_225840747 | 50.10 |
ENST00000366843.2
ENST00000366844.3 |
ENAH
|
enabled homolog (Drosophila) |
chr18_+_657578 | 49.81 |
ENST00000323274.10
|
TYMS
|
thymidylate synthetase |
chr1_+_10459111 | 49.69 |
ENST00000541529.1
ENST00000270776.8 ENST00000483936.1 ENST00000538557.1 |
PGD
|
phosphogluconate dehydrogenase |
chr8_+_38854418 | 49.27 |
ENST00000481513.1
ENST00000487273.2 |
ADAM9
|
ADAM metallopeptidase domain 9 |
chr16_-_87903079 | 48.69 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
chr19_+_6361754 | 48.63 |
ENST00000597326.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
chr20_-_60718430 | 48.44 |
ENST00000370873.4
ENST00000370858.3 |
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7 |
chr12_-_109125285 | 48.13 |
ENST00000552871.1
ENST00000261401.3 |
CORO1C
|
coronin, actin binding protein, 1C |
chr18_+_11981427 | 48.11 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr9_-_113018746 | 47.56 |
ENST00000374515.5
|
TXN
|
thioredoxin |
chr2_+_235860616 | 47.51 |
ENST00000392011.2
|
SH3BP4
|
SH3-domain binding protein 4 |
chr19_+_49496705 | 46.70 |
ENST00000595090.1
|
RUVBL2
|
RuvB-like AAA ATPase 2 |
chr1_+_43824577 | 46.46 |
ENST00000310955.6
|
CDC20
|
cell division cycle 20 |
chrX_-_152989531 | 46.45 |
ENST00000458587.2
ENST00000416815.1 |
BCAP31
|
B-cell receptor-associated protein 31 |
chr18_+_12947981 | 46.23 |
ENST00000262124.11
|
SEH1L
|
SEH1-like (S. cerevisiae) |
chr1_-_212004090 | 46.09 |
ENST00000366997.4
|
LPGAT1
|
lysophosphatidylglycerol acyltransferase 1 |
chr20_-_52210368 | 46.08 |
ENST00000371471.2
|
ZNF217
|
zinc finger protein 217 |
chr17_-_4852332 | 45.87 |
ENST00000572383.1
|
PFN1
|
profilin 1 |
chr18_+_12308231 | 45.78 |
ENST00000590103.1
ENST00000591909.1 ENST00000586653.1 ENST00000592683.1 ENST00000590967.1 ENST00000591208.1 ENST00000591463.1 |
TUBB6
|
tubulin, beta 6 class V |
chr1_-_1822495 | 45.40 |
ENST00000378609.4
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
chr1_+_166808692 | 44.81 |
ENST00000367876.4
|
POGK
|
pogo transposable element with KRAB domain |
chr8_+_145149930 | 44.49 |
ENST00000318911.4
|
CYC1
|
cytochrome c-1 |
chr16_-_81129951 | 44.40 |
ENST00000315467.3
|
GCSH
|
glycine cleavage system protein H (aminomethyl carrier) |
chr20_+_35202909 | 44.39 |
ENST00000558530.1
ENST00000558028.1 ENST00000560025.1 |
TGIF2-C20orf24
TGIF2
|
TGIF2-C20orf24 readthrough TGFB-induced factor homeobox 2 |
chr20_+_32581525 | 44.19 |
ENST00000246194.3
ENST00000413297.1 |
RALY
|
RALY heterogeneous nuclear ribonucleoprotein |
chr11_+_65686802 | 44.18 |
ENST00000376991.2
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr6_-_159065741 | 43.95 |
ENST00000367085.3
ENST00000367089.3 |
DYNLT1
|
dynein, light chain, Tctex-type 1 |
chr20_+_60878005 | 43.94 |
ENST00000253003.2
|
ADRM1
|
adhesion regulating molecule 1 |
chr3_+_23847432 | 43.46 |
ENST00000346855.3
|
UBE2E1
|
ubiquitin-conjugating enzyme E2E 1 |
chr17_+_1733276 | 43.35 |
ENST00000254719.5
|
RPA1
|
replication protein A1, 70kDa |
chr17_-_20946338 | 42.73 |
ENST00000261497.4
|
USP22
|
ubiquitin specific peptidase 22 |
chr19_-_1095330 | 42.62 |
ENST00000586746.1
|
POLR2E
|
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa |
chr1_+_43824669 | 42.39 |
ENST00000372462.1
|
CDC20
|
cell division cycle 20 |
chr18_+_12948000 | 42.34 |
ENST00000585730.1
ENST00000399892.2 ENST00000589446.1 ENST00000587761.1 |
SEH1L
|
SEH1-like (S. cerevisiae) |
chr17_-_73149921 | 41.45 |
ENST00000481647.1
ENST00000470924.1 |
HN1
|
hematological and neurological expressed 1 |
chr2_-_10952832 | 41.35 |
ENST00000540494.1
|
PDIA6
|
protein disulfide isomerase family A, member 6 |
chr12_-_118498958 | 41.19 |
ENST00000315436.3
|
WSB2
|
WD repeat and SOCS box containing 2 |
chr15_-_90777277 | 41.12 |
ENST00000328649.6
|
CIB1
|
calcium and integrin binding 1 (calmyrin) |
chr1_-_8938736 | 41.01 |
ENST00000234590.4
|
ENO1
|
enolase 1, (alpha) |
chr19_-_1568057 | 40.82 |
ENST00000402693.4
ENST00000388824.6 |
MEX3D
|
mex-3 RNA binding family member D |
chr8_-_102217796 | 40.67 |
ENST00000519744.1
ENST00000311212.4 ENST00000521272.1 ENST00000519882.1 |
ZNF706
|
zinc finger protein 706 |
chr16_+_88923494 | 40.39 |
ENST00000567895.1
ENST00000301021.3 ENST00000565504.1 ENST00000567312.1 ENST00000568583.1 ENST00000561840.1 |
TRAPPC2L
|
trafficking protein particle complex 2-like |
chr2_-_179315786 | 39.83 |
ENST00000457633.1
ENST00000438687.3 ENST00000325748.4 |
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator |
chr1_+_236558694 | 39.83 |
ENST00000359362.5
|
EDARADD
|
EDAR-associated death domain |
chr4_+_174089904 | 39.54 |
ENST00000265000.4
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
chr1_-_6453426 | 39.38 |
ENST00000545482.1
|
ACOT7
|
acyl-CoA thioesterase 7 |
chrX_-_153775426 | 39.27 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
chr19_+_54695098 | 39.19 |
ENST00000396388.2
|
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
chr3_-_53290016 | 39.04 |
ENST00000423525.2
ENST00000423516.1 ENST00000296289.6 ENST00000462138.1 |
TKT
|
transketolase |
chr3_-_185542817 | 38.93 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr3_+_100053625 | 38.90 |
ENST00000497785.1
|
NIT2
|
nitrilase family, member 2 |
chr1_+_173446405 | 38.66 |
ENST00000340385.5
|
PRDX6
|
peroxiredoxin 6 |
chr5_+_138089100 | 38.52 |
ENST00000520339.1
ENST00000355078.5 ENST00000302763.7 ENST00000518910.1 |
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa |
chr11_+_65686728 | 38.31 |
ENST00000312515.2
ENST00000525501.1 |
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr18_+_657733 | 38.15 |
ENST00000323250.5
ENST00000323224.7 |
TYMS
|
thymidylate synthetase |
chr19_-_42806723 | 38.13 |
ENST00000262890.3
|
PAFAH1B3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) |
chrX_-_151999269 | 38.07 |
ENST00000370277.3
|
CETN2
|
centrin, EF-hand protein, 2 |
chr1_-_113249948 | 37.93 |
ENST00000339083.7
ENST00000369642.3 |
RHOC
|
ras homolog family member C |
chr15_+_57210961 | 37.88 |
ENST00000557843.1
|
TCF12
|
transcription factor 12 |
chr4_+_57301896 | 37.82 |
ENST00000514888.1
ENST00000264221.2 ENST00000505164.1 |
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
chr9_-_113018835 | 37.81 |
ENST00000374517.5
|
TXN
|
thioredoxin |
chr2_+_122494676 | 37.70 |
ENST00000455432.1
|
TSN
|
translin |
chr12_+_6309517 | 37.65 |
ENST00000382519.4
ENST00000009180.4 |
CD9
|
CD9 molecule |
chr19_+_49496782 | 37.51 |
ENST00000601968.1
ENST00000596837.1 |
RUVBL2
|
RuvB-like AAA ATPase 2 |
chr2_-_179315490 | 37.51 |
ENST00000487082.1
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator |
chrX_-_153707246 | 37.50 |
ENST00000407062.1
|
LAGE3
|
L antigen family, member 3 |
chr10_-_17659234 | 37.50 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr12_+_53342625 | 37.30 |
ENST00000388837.2
ENST00000550600.1 ENST00000388835.3 |
KRT18
|
keratin 18 |
chr14_+_105886150 | 37.03 |
ENST00000331320.7
ENST00000406191.1 |
MTA1
|
metastasis associated 1 |
chr3_+_49711777 | 36.99 |
ENST00000442186.1
ENST00000438011.1 ENST00000457042.1 |
APEH
|
acylaminoacyl-peptide hydrolase |
chr16_+_29817841 | 36.91 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr15_+_52311398 | 36.81 |
ENST00000261845.5
|
MAPK6
|
mitogen-activated protein kinase 6 |
chr19_+_36631867 | 36.80 |
ENST00000588780.1
|
CAPNS1
|
calpain, small subunit 1 |
chr14_-_69446034 | 36.79 |
ENST00000193403.6
|
ACTN1
|
actinin, alpha 1 |
chr14_-_105487381 | 36.78 |
ENST00000392590.3
ENST00000336219.3 |
CDCA4
|
cell division cycle associated 4 |
chr8_-_102217515 | 36.77 |
ENST00000520347.1
ENST00000523922.1 ENST00000520984.1 |
ZNF706
|
zinc finger protein 706 |
chr17_-_4852243 | 36.75 |
ENST00000225655.5
|
PFN1
|
profilin 1 |
chr15_-_72523454 | 36.63 |
ENST00000565154.1
ENST00000565184.1 ENST00000389093.3 ENST00000449901.2 ENST00000335181.5 ENST00000319622.6 |
PKM
|
pyruvate kinase, muscle |
chr20_-_5107180 | 36.59 |
ENST00000379160.3
|
PCNA
|
proliferating cell nuclear antigen |
chr5_-_133340682 | 36.50 |
ENST00000265333.3
|
VDAC1
|
voltage-dependent anion channel 1 |
chr22_+_43547937 | 36.46 |
ENST00000329563.4
|
TSPO
|
translocator protein (18kDa) |
chr19_-_33166045 | 36.42 |
ENST00000586693.3
ENST00000587352.1 ENST00000586463.1 ENST00000306065.4 |
ANKRD27
|
ankyrin repeat domain 27 (VPS9 domain) |
chr22_-_19166343 | 36.42 |
ENST00000215882.5
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
chr17_-_882966 | 36.17 |
ENST00000336868.3
|
NXN
|
nucleoredoxin |
chr7_+_32996997 | 36.15 |
ENST00000242209.4
ENST00000538336.1 ENST00000538443.1 |
FKBP9
|
FK506 binding protein 9, 63 kDa |
chrX_+_133594168 | 36.11 |
ENST00000298556.7
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1 |
chr17_-_62658186 | 36.05 |
ENST00000262435.9
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chr12_+_3068544 | 36.01 |
ENST00000540314.1
ENST00000536826.1 ENST00000359864.2 |
TEAD4
|
TEA domain family member 4 |
chr17_-_80606304 | 35.97 |
ENST00000392325.4
|
WDR45B
|
WD repeat domain 45B |
chr9_+_91926103 | 35.87 |
ENST00000314355.6
|
CKS2
|
CDC28 protein kinase regulatory subunit 2 |
chr18_+_29077990 | 35.84 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
chr7_-_97501432 | 35.82 |
ENST00000394309.3
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing) |
chr8_+_26149007 | 35.73 |
ENST00000380737.3
ENST00000524169.1 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr11_+_64808675 | 35.73 |
ENST00000529996.1
|
SAC3D1
|
SAC3 domain containing 1 |
chr19_-_42806444 | 35.71 |
ENST00000594989.1
|
PAFAH1B3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) |
chr7_-_97501411 | 35.44 |
ENST00000437628.1
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing) |
chr22_-_18257178 | 35.41 |
ENST00000342111.5
|
BID
|
BH3 interacting domain death agonist |
chr5_-_68665469 | 35.37 |
ENST00000217893.5
|
TAF9
|
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa |
chr1_-_94703118 | 35.22 |
ENST00000260526.6
ENST00000370217.3 |
ARHGAP29
|
Rho GTPase activating protein 29 |
chr7_+_56119323 | 35.13 |
ENST00000275603.4
ENST00000335503.3 ENST00000540286.1 |
CCT6A
|
chaperonin containing TCP1, subunit 6A (zeta 1) |
chr10_+_3109695 | 34.98 |
ENST00000381125.4
|
PFKP
|
phosphofructokinase, platelet |
chr10_-_3214965 | 34.84 |
ENST00000451104.2
ENST00000224949.4 ENST00000380989.2 |
PITRM1
|
pitrilysin metallopeptidase 1 |
chr20_+_56884752 | 34.73 |
ENST00000244040.3
|
RAB22A
|
RAB22A, member RAS oncogene family |
chr8_+_145582231 | 34.73 |
ENST00000526338.1
ENST00000402965.1 ENST00000534725.1 ENST00000532887.1 ENST00000329994.2 |
SLC52A2
|
solute carrier family 52 (riboflavin transporter), member 2 |
chr21_-_45196326 | 34.71 |
ENST00000291568.5
|
CSTB
|
cystatin B (stefin B) |
chr22_-_50746027 | 34.70 |
ENST00000425954.1
ENST00000449103.1 |
PLXNB2
|
plexin B2 |
chr6_+_24775153 | 34.68 |
ENST00000356509.3
ENST00000230056.3 |
GMNN
|
geminin, DNA replication inhibitor |
chr7_+_73868220 | 34.68 |
ENST00000455841.2
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
chrX_+_118370288 | 34.53 |
ENST00000535419.1
|
PGRMC1
|
progesterone receptor membrane component 1 |
chr9_+_131451480 | 34.52 |
ENST00000322030.8
|
SET
|
SET nuclear oncogene |
chr2_+_238600933 | 34.52 |
ENST00000420665.1
ENST00000392000.4 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
chr15_-_91537723 | 34.46 |
ENST00000394249.3
ENST00000559811.1 ENST00000442656.2 ENST00000557905.1 ENST00000361919.3 |
PRC1
|
protein regulator of cytokinesis 1 |
chr1_+_26606608 | 34.41 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr8_+_61429728 | 34.40 |
ENST00000529579.1
|
RAB2A
|
RAB2A, member RAS oncogene family |
chr1_+_54411995 | 34.37 |
ENST00000319223.4
ENST00000444987.1 |
LRRC42
|
leucine rich repeat containing 42 |
chr7_+_73868120 | 34.36 |
ENST00000265755.3
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
chr3_-_185542761 | 34.36 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr21_-_46237883 | 34.36 |
ENST00000397893.3
|
SUMO3
|
small ubiquitin-like modifier 3 |
chr1_+_41445413 | 34.26 |
ENST00000541520.1
|
CTPS1
|
CTP synthase 1 |
chr22_-_24322660 | 34.23 |
ENST00000404092.1
|
DDT
|
D-dopachrome tautomerase |
chr11_+_832944 | 34.22 |
ENST00000322008.4
ENST00000397421.1 ENST00000529810.1 ENST00000526693.1 ENST00000525333.1 ENST00000524748.1 ENST00000527341.1 |
CD151
|
CD151 molecule (Raph blood group) |
chr1_-_225615599 | 34.18 |
ENST00000421383.1
ENST00000272163.4 |
LBR
|
lamin B receptor |
chr19_-_2015699 | 34.17 |
ENST00000255608.4
|
BTBD2
|
BTB (POZ) domain containing 2 |
chr7_+_148395733 | 34.02 |
ENST00000602748.1
|
CUL1
|
cullin 1 |
chr2_-_10952922 | 33.93 |
ENST00000272227.3
|
PDIA6
|
protein disulfide isomerase family A, member 6 |
chr13_+_28194873 | 33.86 |
ENST00000302979.3
|
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa |
chr20_-_33872548 | 33.72 |
ENST00000374443.3
|
EIF6
|
eukaryotic translation initiation factor 6 |
chr5_+_68462837 | 33.69 |
ENST00000256442.5
|
CCNB1
|
cyclin B1 |
chr4_-_174256276 | 33.61 |
ENST00000296503.5
|
HMGB2
|
high mobility group box 2 |
chr1_-_150947343 | 33.57 |
ENST00000271688.6
ENST00000368954.5 |
CERS2
|
ceramide synthase 2 |
chr11_+_64808368 | 33.47 |
ENST00000531072.1
ENST00000398846.1 |
SAC3D1
|
SAC3 domain containing 1 |
chr16_-_81129845 | 33.46 |
ENST00000569885.1
ENST00000566566.1 |
GCSH
|
glycine cleavage system protein H (aminomethyl carrier) |
chr2_-_64881018 | 33.37 |
ENST00000313349.3
|
SERTAD2
|
SERTA domain containing 2 |
chr2_+_10262857 | 33.36 |
ENST00000304567.5
|
RRM2
|
ribonucleotide reductase M2 |
chr2_-_174828892 | 33.30 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
chr7_+_98972298 | 33.24 |
ENST00000252725.5
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
chr10_-_17659357 | 33.19 |
ENST00000326961.6
ENST00000361271.3 |
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr19_+_35645817 | 33.13 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr19_+_12917364 | 33.11 |
ENST00000221486.4
|
RNASEH2A
|
ribonuclease H2, subunit A |
chr20_+_17550691 | 33.07 |
ENST00000474024.1
|
DSTN
|
destrin (actin depolymerizing factor) |
chr19_-_48894762 | 33.03 |
ENST00000600980.1
ENST00000330720.2 |
KDELR1
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
chr1_-_68299130 | 32.99 |
ENST00000370982.3
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12 |
chr6_+_3000057 | 32.92 |
ENST00000397717.2
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
chr16_-_84651673 | 32.90 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr15_+_66161802 | 32.88 |
ENST00000566233.1
ENST00000565075.1 ENST00000435304.2 |
RAB11A
|
RAB11A, member RAS oncogene family |
chr4_-_100871506 | 32.82 |
ENST00000296417.5
|
H2AFZ
|
H2A histone family, member Z |
chr9_+_131452239 | 32.77 |
ENST00000372688.4
ENST00000372686.5 |
SET
|
SET nuclear oncogene |
chr19_+_48824711 | 32.71 |
ENST00000599704.1
|
EMP3
|
epithelial membrane protein 3 |
chr12_-_58146128 | 32.66 |
ENST00000551800.1
ENST00000549606.1 ENST00000257904.6 |
CDK4
|
cyclin-dependent kinase 4 |
chr3_+_171758344 | 32.65 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
chr7_+_16685756 | 32.58 |
ENST00000415365.1
ENST00000258761.3 ENST00000433922.2 ENST00000452975.2 ENST00000405202.1 |
BZW2
|
basic leucine zipper and W2 domains 2 |
chr20_-_33872518 | 32.46 |
ENST00000374436.3
|
EIF6
|
eukaryotic translation initiation factor 6 |
chr6_+_138725343 | 32.46 |
ENST00000607197.1
ENST00000367697.3 |
HEBP2
|
heme binding protein 2 |
chr19_+_16187816 | 32.39 |
ENST00000588410.1
|
TPM4
|
tropomyosin 4 |
chr5_+_172385732 | 32.36 |
ENST00000519974.1
ENST00000521476.1 |
RPL26L1
|
ribosomal protein L26-like 1 |
chr1_-_152009460 | 32.16 |
ENST00000271638.2
|
S100A11
|
S100 calcium binding protein A11 |
chr2_+_172778952 | 32.12 |
ENST00000392584.1
ENST00000264108.4 |
HAT1
|
histone acetyltransferase 1 |
chr3_+_49711391 | 32.11 |
ENST00000296456.5
ENST00000449966.1 |
APEH
|
acylaminoacyl-peptide hydrolase |
chr1_+_955448 | 32.04 |
ENST00000379370.2
|
AGRN
|
agrin |
chr2_-_215674374 | 32.02 |
ENST00000449967.2
ENST00000421162.1 ENST00000260947.4 |
BARD1
|
BRCA1 associated RING domain 1 |
chr16_+_89989687 | 32.01 |
ENST00000315491.7
ENST00000555576.1 ENST00000554336.1 ENST00000553967.1 |
TUBB3
|
Tubulin beta-3 chain |
chr7_+_116166331 | 32.00 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr17_-_73150599 | 31.91 |
ENST00000392566.2
ENST00000581874.1 |
HN1
|
hematological and neurological expressed 1 |
chr20_+_43514320 | 31.86 |
ENST00000372839.3
ENST00000428262.1 ENST00000445830.1 |
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
chr17_-_4269768 | 31.85 |
ENST00000396981.2
|
UBE2G1
|
ubiquitin-conjugating enzyme E2G 1 |
chr16_-_84651647 | 31.74 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr1_-_24126892 | 31.71 |
ENST00000374497.3
ENST00000425913.1 |
GALE
|
UDP-galactose-4-epimerase |
chr11_+_64009072 | 31.68 |
ENST00000535135.1
ENST00000394540.3 |
FKBP2
|
FK506 binding protein 2, 13kDa |
chr1_+_182992545 | 31.65 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
chr8_+_145582217 | 31.61 |
ENST00000530047.1
ENST00000527078.1 |
SLC52A2
|
solute carrier family 52 (riboflavin transporter), member 2 |
chr11_-_102323489 | 31.60 |
ENST00000361236.3
|
TMEM123
|
transmembrane protein 123 |
chr20_+_388679 | 31.56 |
ENST00000356286.5
ENST00000475269.1 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr1_+_94883931 | 31.52 |
ENST00000394233.2
ENST00000454898.2 ENST00000536817.1 |
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
chr1_+_65613340 | 31.49 |
ENST00000546702.1
|
AK4
|
adenylate kinase 4 |
chr20_+_17550489 | 31.44 |
ENST00000246069.7
|
DSTN
|
destrin (actin depolymerizing factor) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
38.3 | 153.2 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
34.5 | 137.9 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
33.7 | 101.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
31.5 | 126.0 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
28.3 | 85.0 | GO:0046680 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
26.8 | 80.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
25.8 | 103.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
25.7 | 102.9 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
23.9 | 71.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
22.7 | 68.2 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
22.7 | 113.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
22.4 | 22.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
22.1 | 44.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
21.8 | 21.8 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
21.8 | 87.3 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
21.2 | 63.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
21.1 | 21.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
20.7 | 62.0 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
20.0 | 60.1 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
19.9 | 99.5 | GO:0015862 | uridine transport(GO:0015862) |
19.7 | 78.6 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
19.6 | 58.7 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
19.5 | 58.4 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
19.4 | 77.6 | GO:0032218 | riboflavin transport(GO:0032218) |
19.3 | 77.4 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
19.1 | 95.5 | GO:0035900 | response to isolation stress(GO:0035900) |
19.1 | 38.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
19.1 | 114.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
18.4 | 73.7 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
18.4 | 55.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
17.7 | 124.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
17.7 | 88.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
17.5 | 52.6 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
17.5 | 52.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
17.3 | 103.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
17.2 | 86.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
17.2 | 120.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
17.2 | 103.0 | GO:0015853 | adenine transport(GO:0015853) |
16.7 | 50.0 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
16.6 | 49.9 | GO:0044209 | AMP salvage(GO:0044209) |
16.6 | 66.4 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
16.5 | 16.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
16.3 | 65.1 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
16.2 | 81.0 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
16.2 | 16.2 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
15.7 | 78.4 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
15.6 | 46.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
15.5 | 108.8 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
15.4 | 46.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
15.4 | 46.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
15.4 | 15.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
15.3 | 152.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
15.3 | 61.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
15.2 | 45.7 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
15.2 | 60.9 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
15.1 | 151.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
15.0 | 60.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
15.0 | 134.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
14.9 | 44.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
14.9 | 44.7 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
14.9 | 44.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
14.8 | 29.6 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
14.8 | 44.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
14.7 | 44.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
14.6 | 87.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
14.6 | 102.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
14.5 | 72.6 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
14.5 | 58.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
14.4 | 57.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
14.3 | 42.9 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
14.3 | 14.3 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
14.2 | 70.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
14.1 | 42.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
14.1 | 70.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
14.1 | 14.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
14.0 | 42.0 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
14.0 | 55.9 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
13.8 | 69.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
13.6 | 40.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
13.5 | 40.4 | GO:0061198 | fungiform papilla formation(GO:0061198) |
13.4 | 80.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
13.4 | 66.9 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
13.4 | 53.4 | GO:0043335 | protein unfolding(GO:0043335) |
13.3 | 66.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
13.2 | 131.9 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
13.1 | 130.6 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
13.0 | 52.0 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
12.9 | 38.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
12.9 | 38.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
12.8 | 38.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
12.6 | 37.9 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
12.6 | 138.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
12.6 | 12.6 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
12.6 | 37.7 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
12.5 | 99.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
12.4 | 24.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
12.2 | 48.9 | GO:0046108 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
12.1 | 60.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) negative regulation of male germ cell proliferation(GO:2000255) |
12.1 | 84.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
12.0 | 36.0 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
11.8 | 189.4 | GO:0043248 | proteasome assembly(GO:0043248) |
11.8 | 47.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
11.8 | 35.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
11.8 | 58.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
11.7 | 46.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
11.7 | 11.7 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
11.7 | 11.7 | GO:0046102 | inosine metabolic process(GO:0046102) |
11.6 | 220.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
11.5 | 11.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
11.5 | 11.5 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
11.5 | 11.5 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
11.5 | 149.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
11.5 | 80.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
11.5 | 11.5 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
11.4 | 45.8 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
11.4 | 91.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
11.3 | 45.3 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
11.3 | 34.0 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
11.3 | 67.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
11.3 | 101.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
11.2 | 56.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
11.2 | 33.7 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
11.2 | 33.5 | GO:0018201 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
11.1 | 22.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
11.0 | 55.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
11.0 | 76.8 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
11.0 | 43.9 | GO:0021564 | vagus nerve development(GO:0021564) |
10.9 | 152.7 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
10.9 | 65.2 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
10.8 | 10.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
10.6 | 10.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
10.6 | 138.3 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
10.6 | 53.1 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
10.6 | 31.7 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
10.6 | 95.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
10.6 | 21.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
10.5 | 105.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
10.4 | 52.0 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
10.4 | 62.2 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
10.4 | 62.2 | GO:0030421 | defecation(GO:0030421) |
10.3 | 31.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
10.3 | 41.2 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
10.2 | 30.7 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
10.2 | 40.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
10.2 | 71.2 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
10.2 | 30.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
10.1 | 60.8 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
10.1 | 40.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
10.1 | 30.2 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
10.1 | 50.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
10.0 | 30.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
10.0 | 30.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
10.0 | 79.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
9.9 | 49.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
9.9 | 69.5 | GO:0007144 | female meiosis I(GO:0007144) |
9.8 | 29.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
9.8 | 98.0 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
9.8 | 58.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
9.7 | 9.7 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
9.7 | 58.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
9.6 | 48.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
9.6 | 19.1 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
9.5 | 142.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
9.5 | 38.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
9.5 | 28.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
9.4 | 66.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
9.4 | 28.3 | GO:0043542 | endothelial cell migration(GO:0043542) |
9.4 | 28.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
9.3 | 28.0 | GO:0018158 | protein oxidation(GO:0018158) |
9.3 | 65.4 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
9.3 | 74.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
9.3 | 130.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
9.3 | 37.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
9.1 | 36.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
9.1 | 27.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
9.0 | 9.0 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
9.0 | 189.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
9.0 | 9.0 | GO:0010225 | response to UV-C(GO:0010225) |
9.0 | 26.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
8.9 | 26.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
8.9 | 89.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
8.9 | 17.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
8.9 | 62.0 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
8.8 | 44.2 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
8.8 | 8.8 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
8.8 | 26.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
8.8 | 35.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
8.8 | 17.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
8.8 | 26.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
8.8 | 26.3 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
8.7 | 87.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
8.7 | 43.6 | GO:0030047 | actin modification(GO:0030047) |
8.7 | 644.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
8.7 | 104.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
8.7 | 69.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
8.6 | 25.9 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
8.6 | 25.8 | GO:0070631 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
8.6 | 8.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
8.6 | 17.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
8.6 | 17.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
8.6 | 25.7 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
8.5 | 68.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
8.5 | 8.5 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
8.5 | 34.1 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
8.5 | 25.6 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
8.5 | 34.0 | GO:1902462 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
8.5 | 34.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
8.5 | 25.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
8.4 | 33.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
8.4 | 8.4 | GO:0015846 | polyamine transport(GO:0015846) |
8.3 | 58.4 | GO:0042262 | DNA protection(GO:0042262) |
8.3 | 116.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
8.3 | 33.2 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
8.3 | 24.9 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
8.3 | 16.6 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
8.3 | 16.6 | GO:0015866 | ADP transport(GO:0015866) |
8.3 | 49.5 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
8.2 | 8.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
8.2 | 32.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
8.1 | 32.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
8.1 | 129.7 | GO:0000338 | protein deneddylation(GO:0000338) |
8.1 | 24.3 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
8.1 | 97.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
8.1 | 48.6 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
8.1 | 24.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
8.0 | 40.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
8.0 | 16.0 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) chromosome movement towards spindle pole(GO:0051305) |
8.0 | 31.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
7.9 | 31.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
7.9 | 47.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
7.9 | 23.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
7.8 | 47.0 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
7.8 | 23.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
7.8 | 23.4 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
7.8 | 23.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
7.8 | 46.7 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
7.8 | 23.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
7.8 | 643.8 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
7.7 | 340.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
7.7 | 30.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
7.7 | 15.4 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
7.7 | 38.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
7.7 | 15.4 | GO:0002188 | translation reinitiation(GO:0002188) |
7.7 | 23.1 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
7.7 | 23.0 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
7.7 | 53.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
7.7 | 23.0 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
7.7 | 15.3 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
7.6 | 53.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
7.6 | 22.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
7.6 | 22.8 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
7.6 | 22.7 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
7.5 | 30.2 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
7.5 | 30.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
7.5 | 59.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
7.5 | 22.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
7.4 | 51.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
7.4 | 73.9 | GO:0060056 | mammary gland involution(GO:0060056) |
7.4 | 155.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
7.4 | 22.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
7.3 | 22.0 | GO:0006404 | RNA import into nucleus(GO:0006404) |
7.3 | 14.6 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
7.3 | 21.8 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
7.3 | 7.3 | GO:0048254 | snoRNA localization(GO:0048254) |
7.3 | 7.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
7.2 | 43.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
7.2 | 7.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
7.1 | 7.1 | GO:0032506 | cytokinetic process(GO:0032506) |
7.1 | 35.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
7.1 | 7.1 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
7.1 | 14.2 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
7.1 | 28.3 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
7.1 | 7.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
7.0 | 42.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
7.0 | 168.7 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
7.0 | 49.1 | GO:0070269 | pyroptosis(GO:0070269) |
7.0 | 21.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
7.0 | 42.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
7.0 | 215.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
6.9 | 13.8 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
6.9 | 6.9 | GO:0060613 | fat pad development(GO:0060613) |
6.9 | 48.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
6.8 | 6.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
6.8 | 47.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
6.8 | 6.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
6.8 | 6.8 | GO:0021511 | spinal cord patterning(GO:0021511) |
6.8 | 27.0 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
6.7 | 54.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
6.7 | 67.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
6.7 | 33.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
6.7 | 40.3 | GO:0007296 | vitellogenesis(GO:0007296) |
6.7 | 6.7 | GO:0071035 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
6.7 | 73.7 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
6.7 | 66.9 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
6.7 | 106.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
6.7 | 73.5 | GO:1901070 | GTP biosynthetic process(GO:0006183) guanosine-containing compound biosynthetic process(GO:1901070) |
6.6 | 13.3 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
6.6 | 53.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
6.6 | 13.3 | GO:1903911 | positive regulation of receptor clustering(GO:1903911) |
6.6 | 456.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
6.6 | 79.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
6.6 | 32.9 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
6.6 | 65.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
6.5 | 19.6 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
6.5 | 13.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
6.5 | 117.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
6.5 | 297.6 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
6.5 | 58.1 | GO:0009414 | response to water deprivation(GO:0009414) |
6.5 | 32.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
6.4 | 19.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
6.4 | 6.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
6.4 | 32.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
6.4 | 25.6 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
6.4 | 89.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
6.4 | 19.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
6.4 | 38.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
6.3 | 6.3 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
6.3 | 12.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
6.3 | 25.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
6.3 | 6.3 | GO:2000395 | ubiquitin-dependent endocytosis(GO:0070086) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
6.3 | 31.5 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
6.3 | 206.3 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
6.2 | 24.9 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
6.2 | 24.9 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
6.2 | 18.6 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
6.2 | 6.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
6.2 | 24.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
6.2 | 30.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
6.2 | 18.5 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
6.1 | 30.7 | GO:0048478 | replication fork protection(GO:0048478) |
6.1 | 42.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
6.1 | 36.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
6.1 | 12.2 | GO:1901656 | glycoside transport(GO:1901656) |
6.1 | 177.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
6.1 | 6.1 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
6.1 | 67.1 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
6.1 | 18.3 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
6.0 | 72.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
6.0 | 24.2 | GO:0072683 | T cell extravasation(GO:0072683) |
6.0 | 18.1 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
6.0 | 30.2 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
6.0 | 12.1 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
6.0 | 48.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
6.0 | 6.0 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
6.0 | 48.0 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
6.0 | 23.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
5.9 | 17.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
5.9 | 11.9 | GO:0006740 | NADPH regeneration(GO:0006740) |
5.9 | 17.6 | GO:0033341 | regulation of collagen binding(GO:0033341) |
5.9 | 17.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
5.9 | 46.9 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
5.9 | 17.6 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
5.8 | 11.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
5.8 | 17.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
5.8 | 126.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
5.7 | 23.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
5.7 | 149.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
5.7 | 51.6 | GO:0006415 | translational termination(GO:0006415) |
5.7 | 5.7 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
5.7 | 34.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
5.7 | 17.0 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
5.7 | 22.7 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
5.7 | 45.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
5.7 | 34.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
5.7 | 28.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
5.6 | 39.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
5.6 | 16.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
5.6 | 50.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
5.6 | 28.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
5.6 | 22.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
5.6 | 11.1 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
5.5 | 5.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
5.5 | 16.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
5.5 | 33.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
5.5 | 11.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
5.5 | 5.5 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
5.5 | 16.4 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
5.4 | 5.4 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
5.4 | 86.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
5.4 | 21.6 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
5.4 | 21.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
5.4 | 16.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
5.4 | 26.9 | GO:1905214 | regulation of RNA binding(GO:1905214) |
5.4 | 26.9 | GO:0070836 | caveola assembly(GO:0070836) |
5.4 | 80.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
5.3 | 21.4 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
5.3 | 42.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
5.3 | 16.0 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
5.3 | 26.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
5.3 | 21.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
5.3 | 15.9 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
5.3 | 5.3 | GO:0034214 | protein hexamerization(GO:0034214) |
5.3 | 47.4 | GO:0060717 | chorion development(GO:0060717) |
5.3 | 189.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
5.2 | 26.0 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
5.2 | 26.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
5.2 | 15.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
5.1 | 5.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
5.1 | 36.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
5.1 | 41.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
5.1 | 15.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
5.1 | 20.5 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) |
5.1 | 10.2 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
5.1 | 5.1 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
5.1 | 10.2 | GO:0035822 | gene conversion(GO:0035822) |
5.1 | 5.1 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
5.1 | 5.1 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
5.1 | 15.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
5.0 | 15.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
5.0 | 15.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
5.0 | 55.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
5.0 | 30.1 | GO:0042407 | cristae formation(GO:0042407) |
5.0 | 14.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
5.0 | 5.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
4.9 | 4.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
4.9 | 371.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
4.9 | 9.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
4.9 | 9.7 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
4.8 | 4.8 | GO:0021539 | subthalamus development(GO:0021539) |
4.8 | 19.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
4.8 | 14.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
4.8 | 38.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
4.8 | 9.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
4.8 | 9.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
4.7 | 23.7 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
4.7 | 42.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
4.7 | 28.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
4.7 | 18.6 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
4.6 | 4.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
4.6 | 41.8 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
4.6 | 46.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
4.6 | 4.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
4.6 | 36.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
4.6 | 9.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
4.6 | 4.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
4.6 | 41.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
4.6 | 50.2 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
4.5 | 18.1 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
4.5 | 54.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
4.5 | 13.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
4.5 | 17.9 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
4.5 | 17.9 | GO:0035973 | aggrephagy(GO:0035973) |
4.5 | 8.9 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
4.4 | 17.8 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
4.4 | 4.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
4.4 | 17.7 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
4.4 | 13.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
4.4 | 13.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
4.4 | 44.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
4.4 | 17.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
4.4 | 87.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
4.4 | 4.4 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
4.4 | 4.4 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
4.4 | 8.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
4.4 | 39.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
4.4 | 8.8 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
4.4 | 8.7 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
4.4 | 8.7 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
4.3 | 4.3 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of terminal mannose on C branch(GO:0036510) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
4.3 | 30.3 | GO:0030091 | protein repair(GO:0030091) |
4.3 | 43.3 | GO:0045116 | protein neddylation(GO:0045116) |
4.3 | 12.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
4.3 | 21.6 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
4.3 | 12.9 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
4.3 | 8.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
4.3 | 34.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
4.3 | 4.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
4.2 | 63.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
4.2 | 21.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
4.2 | 12.7 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
4.2 | 4.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
4.2 | 25.2 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
4.2 | 62.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
4.2 | 117.2 | GO:0032392 | DNA geometric change(GO:0032392) |
4.2 | 8.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
4.2 | 41.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
4.1 | 45.5 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
4.1 | 20.7 | GO:0007619 | courtship behavior(GO:0007619) |
4.1 | 12.3 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
4.1 | 89.8 | GO:0034080 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
4.1 | 12.2 | GO:0006574 | valine catabolic process(GO:0006574) |
4.1 | 8.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
4.1 | 8.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
4.0 | 4.0 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) |
4.0 | 20.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
4.0 | 24.1 | GO:1901163 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
4.0 | 20.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
4.0 | 12.0 | GO:0048382 | mesendoderm development(GO:0048382) |
4.0 | 4.0 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
4.0 | 4.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
4.0 | 4.0 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
4.0 | 7.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
3.9 | 39.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
3.9 | 3.9 | GO:0010458 | exit from mitosis(GO:0010458) |
3.9 | 50.8 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
3.9 | 23.4 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
3.9 | 93.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
3.9 | 19.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
3.9 | 19.3 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
3.9 | 7.7 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
3.8 | 3.8 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
3.8 | 50.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
3.8 | 19.2 | GO:0003069 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
3.8 | 65.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
3.8 | 168.4 | GO:0035329 | hippo signaling(GO:0035329) |
3.8 | 26.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
3.8 | 7.6 | GO:0046031 | ADP metabolic process(GO:0046031) |
3.8 | 11.4 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
3.8 | 7.6 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
3.8 | 64.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
3.8 | 37.6 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
3.7 | 3.7 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
3.7 | 22.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
3.7 | 26.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
3.7 | 14.9 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
3.7 | 18.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
3.7 | 55.4 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
3.7 | 11.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
3.6 | 10.9 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
3.6 | 18.2 | GO:0060356 | leucine import(GO:0060356) |
3.6 | 10.9 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
3.6 | 57.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
3.6 | 115.5 | GO:0061620 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
3.6 | 7.2 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
3.6 | 97.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
3.6 | 10.8 | GO:0001832 | blastocyst growth(GO:0001832) inner cell mass cell proliferation(GO:0001833) |
3.6 | 207.9 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
3.6 | 7.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
3.6 | 10.7 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
3.6 | 10.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
3.6 | 10.7 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
3.5 | 21.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
3.5 | 155.9 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
3.5 | 10.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
3.5 | 42.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
3.5 | 14.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
3.5 | 278.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
3.5 | 24.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
3.5 | 28.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
3.5 | 45.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
3.5 | 3.5 | GO:0046677 | response to antibiotic(GO:0046677) |
3.5 | 139.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
3.5 | 6.9 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
3.5 | 6.9 | GO:0019079 | viral genome replication(GO:0019079) |
3.5 | 34.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
3.4 | 6.9 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
3.4 | 34.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
3.4 | 209.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
3.4 | 13.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
3.4 | 3.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
3.4 | 30.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
3.4 | 13.7 | GO:0045136 | thelarche(GO:0042695) development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
3.4 | 10.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
3.4 | 91.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
3.4 | 3.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
3.4 | 6.8 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
3.4 | 13.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
3.4 | 64.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
3.4 | 3.4 | GO:0072289 | retinal rod cell differentiation(GO:0060221) metanephric nephron tubule formation(GO:0072289) |
3.4 | 108.1 | GO:0090383 | phagosome acidification(GO:0090383) |
3.4 | 6.7 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
3.4 | 3.4 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
3.3 | 23.4 | GO:0046618 | drug export(GO:0046618) |
3.3 | 13.4 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
3.3 | 10.0 | GO:0060166 | olfactory pit development(GO:0060166) |
3.3 | 3.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
3.3 | 16.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
3.3 | 13.2 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) |
3.3 | 13.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
3.3 | 13.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
3.3 | 3.3 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
3.3 | 9.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
3.3 | 3.3 | GO:0043144 | snoRNA processing(GO:0043144) |
3.3 | 9.8 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
3.3 | 19.6 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
3.3 | 32.6 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
3.3 | 16.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
3.2 | 84.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
3.2 | 9.7 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
3.2 | 6.4 | GO:1904044 | response to aldosterone(GO:1904044) |
3.2 | 70.3 | GO:0042255 | ribosome assembly(GO:0042255) |
3.2 | 16.0 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
3.2 | 19.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
3.2 | 22.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
3.2 | 22.3 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
3.2 | 15.9 | GO:0046689 | response to mercury ion(GO:0046689) |
3.2 | 15.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
3.2 | 31.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
3.2 | 214.7 | GO:0048207 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
3.2 | 44.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
3.2 | 9.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
3.1 | 25.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
3.1 | 6.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
3.1 | 12.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
3.1 | 21.9 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
3.1 | 3.1 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
3.1 | 9.3 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
3.1 | 12.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
3.1 | 6.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
3.1 | 21.7 | GO:0051014 | actin filament severing(GO:0051014) |
3.1 | 3.1 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
3.1 | 12.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
3.1 | 9.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
3.0 | 36.6 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
3.0 | 3.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
3.0 | 12.2 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
3.0 | 39.4 | GO:0007097 | nuclear migration(GO:0007097) |
3.0 | 12.1 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
3.0 | 33.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
3.0 | 21.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
3.0 | 30.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
3.0 | 26.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
3.0 | 38.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
3.0 | 8.9 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
3.0 | 11.8 | GO:0048102 | autophagic cell death(GO:0048102) |
3.0 | 8.9 | GO:0070512 | negative regulation of histone H3-K4 methylation(GO:0051572) regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
2.9 | 23.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
2.9 | 52.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.9 | 8.8 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
2.9 | 32.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
2.9 | 11.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
2.9 | 11.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
2.9 | 20.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
2.9 | 40.6 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
2.9 | 28.9 | GO:0070986 | left/right axis specification(GO:0070986) |
2.9 | 2.9 | GO:0010039 | response to iron ion(GO:0010039) |
2.9 | 14.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
2.9 | 2.9 | GO:0042180 | cellular ketone metabolic process(GO:0042180) |
2.9 | 2.9 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) negative regulation of phospholipid biosynthetic process(GO:0071072) |
2.8 | 11.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.8 | 17.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
2.8 | 5.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
2.8 | 87.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
2.8 | 8.5 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
2.8 | 19.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.8 | 14.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
2.8 | 27.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
2.8 | 16.7 | GO:0031017 | exocrine pancreas development(GO:0031017) |
2.8 | 8.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
2.8 | 2.8 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
2.8 | 22.2 | GO:0030647 | aminoglycoside antibiotic metabolic process(GO:0030647) |
2.8 | 5.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
2.8 | 5.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
2.8 | 24.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
2.8 | 5.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
2.8 | 13.8 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
2.7 | 22.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
2.7 | 51.9 | GO:0006465 | signal peptide processing(GO:0006465) |
2.7 | 2.7 | GO:0007051 | spindle organization(GO:0007051) |
2.7 | 5.4 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
2.7 | 32.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
2.7 | 8.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
2.7 | 51.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
2.7 | 8.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
2.7 | 5.4 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
2.7 | 8.0 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
2.7 | 138.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
2.7 | 13.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
2.6 | 2.6 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
2.6 | 74.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
2.6 | 5.3 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
2.6 | 13.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
2.6 | 13.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
2.6 | 10.5 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
2.6 | 2.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
2.6 | 2.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
2.6 | 2.6 | GO:0060296 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
2.6 | 10.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
2.6 | 263.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
2.6 | 18.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
2.6 | 15.4 | GO:0051639 | actin filament network formation(GO:0051639) |
2.6 | 5.1 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
2.6 | 5.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
2.6 | 30.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
2.6 | 12.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
2.6 | 20.5 | GO:0097286 | iron ion import(GO:0097286) |
2.6 | 5.1 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
2.5 | 10.2 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
2.5 | 5.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
2.5 | 30.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
2.5 | 7.6 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
2.5 | 32.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
2.5 | 15.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
2.5 | 12.6 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
2.5 | 2.5 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
2.5 | 30.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
2.5 | 14.9 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
2.5 | 12.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
2.4 | 17.1 | GO:0090382 | phagosome maturation(GO:0090382) |
2.4 | 4.9 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
2.4 | 7.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
2.4 | 19.5 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
2.4 | 7.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
2.4 | 9.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
2.4 | 14.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
2.4 | 9.6 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
2.4 | 2.4 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
2.4 | 7.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
2.4 | 2.4 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
2.4 | 35.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
2.4 | 16.7 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
2.4 | 16.7 | GO:0007379 | segment specification(GO:0007379) |
2.4 | 11.9 | GO:0015677 | copper ion import(GO:0015677) |
2.4 | 26.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
2.4 | 4.7 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
2.4 | 4.7 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
2.4 | 23.7 | GO:0006907 | pinocytosis(GO:0006907) |
2.3 | 9.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
2.3 | 2.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
2.3 | 7.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
2.3 | 7.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.3 | 7.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.3 | 2.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
2.3 | 9.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
2.3 | 30.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
2.3 | 4.6 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
2.3 | 9.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
2.3 | 6.8 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
2.3 | 18.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
2.3 | 36.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
2.3 | 2.3 | GO:0046686 | response to cadmium ion(GO:0046686) |
2.2 | 6.7 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
2.2 | 8.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
2.2 | 4.5 | GO:0051795 | positive regulation of catagen(GO:0051795) |
2.2 | 4.5 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
2.2 | 132.0 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
2.2 | 11.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
2.2 | 6.6 | GO:0048539 | bone marrow development(GO:0048539) |
2.2 | 30.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
2.2 | 6.6 | GO:1901355 | response to rapamycin(GO:1901355) |
2.2 | 11.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
2.2 | 21.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
2.2 | 10.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
2.1 | 15.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
2.1 | 4.3 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
2.1 | 66.4 | GO:0045214 | sarcomere organization(GO:0045214) |
2.1 | 25.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
2.1 | 10.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.1 | 47.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
2.1 | 6.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
2.1 | 2.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
2.1 | 27.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
2.1 | 6.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
2.1 | 6.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
2.1 | 55.8 | GO:0015893 | drug transport(GO:0015893) |
2.1 | 4.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
2.1 | 8.3 | GO:0003409 | optic cup structural organization(GO:0003409) |
2.1 | 2.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
2.1 | 6.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.1 | 8.2 | GO:0009651 | response to salt stress(GO:0009651) |
2.1 | 16.5 | GO:0042182 | ketone catabolic process(GO:0042182) |
2.1 | 72.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
2.1 | 6.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) negative regulation of immunological synapse formation(GO:2000521) |
2.1 | 4.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
2.0 | 2.0 | GO:0070671 | response to interleukin-12(GO:0070671) |
2.0 | 40.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
2.0 | 4.1 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
2.0 | 16.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
2.0 | 2.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
2.0 | 6.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
2.0 | 10.0 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
2.0 | 48.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
2.0 | 6.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
2.0 | 2.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.0 | 53.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
2.0 | 67.6 | GO:0006414 | translational elongation(GO:0006414) |
2.0 | 11.8 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
2.0 | 17.7 | GO:0006552 | leucine catabolic process(GO:0006552) |
2.0 | 13.7 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
2.0 | 5.9 | GO:0016559 | peroxisome fission(GO:0016559) |
2.0 | 31.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
2.0 | 11.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
2.0 | 9.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.9 | 3.9 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
1.9 | 7.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.9 | 9.7 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
1.9 | 36.7 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
1.9 | 19.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.9 | 7.7 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
1.9 | 26.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.9 | 9.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.9 | 3.8 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
1.9 | 3.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.9 | 13.3 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
1.9 | 11.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
1.9 | 22.7 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
1.9 | 3.8 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.9 | 16.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
1.9 | 1.9 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
1.9 | 1.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.9 | 3.7 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
1.9 | 9.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.9 | 5.6 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.9 | 5.6 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.9 | 1.9 | GO:0040031 | snRNA modification(GO:0040031) |
1.8 | 7.4 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.8 | 3.7 | GO:0007518 | myoblast fate determination(GO:0007518) |
1.8 | 7.4 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
1.8 | 9.1 | GO:0072718 | response to cisplatin(GO:0072718) |
1.8 | 72.8 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.8 | 5.4 | GO:0002934 | desmosome organization(GO:0002934) |
1.8 | 14.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.8 | 1.8 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
1.8 | 5.4 | GO:0008356 | asymmetric cell division(GO:0008356) |
1.8 | 23.2 | GO:0006825 | copper ion transport(GO:0006825) |
1.8 | 10.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.8 | 21.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.8 | 1.8 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.8 | 5.3 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
1.8 | 7.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
1.8 | 5.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
1.8 | 14.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.8 | 5.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
1.7 | 45.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
1.7 | 13.9 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
1.7 | 36.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
1.7 | 3.5 | GO:0017145 | stem cell division(GO:0017145) |
1.7 | 1.7 | GO:0072666 | establishment of protein localization to vacuole(GO:0072666) |
1.7 | 24.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
1.7 | 18.9 | GO:0033260 | nuclear DNA replication(GO:0033260) |
1.7 | 6.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
1.7 | 25.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
1.7 | 5.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
1.7 | 11.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.7 | 5.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
1.7 | 6.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.7 | 5.0 | GO:2000861 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
1.7 | 114.4 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
1.7 | 34.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
1.6 | 16.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.6 | 52.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.6 | 16.4 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
1.6 | 11.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.6 | 3.3 | GO:1901143 | insulin catabolic process(GO:1901143) |
1.6 | 1.6 | GO:0022615 | protein to membrane docking(GO:0022615) |
1.6 | 6.5 | GO:0042026 | protein refolding(GO:0042026) |
1.6 | 1.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.6 | 8.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
1.6 | 1.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.6 | 4.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.6 | 1.6 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
1.6 | 9.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
1.6 | 3.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.6 | 7.9 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
1.6 | 4.7 | GO:0050894 | determination of affect(GO:0050894) |
1.5 | 3.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
1.5 | 29.3 | GO:0044804 | nucleophagy(GO:0044804) |
1.5 | 1.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.5 | 4.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
1.5 | 9.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.5 | 4.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
1.5 | 9.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.5 | 9.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.5 | 7.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
1.5 | 4.5 | GO:1901253 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
1.5 | 3.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
1.5 | 5.9 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
1.5 | 3.0 | GO:0046449 | creatinine metabolic process(GO:0046449) |
1.5 | 4.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.5 | 8.9 | GO:0051451 | myoblast migration(GO:0051451) |
1.5 | 1.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
1.5 | 83.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
1.5 | 7.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.5 | 4.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
1.5 | 2.9 | GO:0070988 | demethylation(GO:0070988) |
1.5 | 8.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
1.5 | 4.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.5 | 2.9 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.5 | 1.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.4 | 4.3 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
1.4 | 7.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
1.4 | 33.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.4 | 7.2 | GO:0001302 | replicative cell aging(GO:0001302) |
1.4 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.4 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.4 | 1.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
1.4 | 4.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
1.4 | 8.6 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
1.4 | 8.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
1.4 | 10.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.4 | 2.8 | GO:0035989 | tendon development(GO:0035989) |
1.4 | 11.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
1.4 | 5.7 | GO:1901098 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
1.4 | 8.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
1.4 | 9.9 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
1.4 | 2.8 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
1.4 | 1.4 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
1.4 | 2.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.4 | 2.8 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
1.4 | 6.9 | GO:0016553 | base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
1.4 | 8.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.4 | 17.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
1.4 | 6.8 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
1.3 | 13.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
1.3 | 8.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.3 | 4.0 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
1.3 | 15.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
1.3 | 2.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
1.3 | 9.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.3 | 2.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.3 | 32.5 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
1.3 | 1.3 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
1.3 | 9.0 | GO:0031274 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
1.3 | 15.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
1.3 | 5.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.3 | 2.6 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
1.3 | 2.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.3 | 1.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.3 | 2.5 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
1.3 | 5.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.3 | 10.0 | GO:0051601 | exocyst localization(GO:0051601) |
1.3 | 35.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
1.3 | 45.1 | GO:0031100 | organ regeneration(GO:0031100) |
1.3 | 36.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
1.2 | 9.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
1.2 | 2.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
1.2 | 2.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.2 | 3.7 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
1.2 | 4.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.2 | 3.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.2 | 4.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
1.2 | 6.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.2 | 5.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.2 | 2.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
1.2 | 2.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.2 | 1.2 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
1.2 | 9.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
1.2 | 4.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
1.2 | 8.2 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
1.2 | 5.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.1 | 3.4 | GO:0033197 | response to vitamin E(GO:0033197) |
1.1 | 5.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
1.1 | 2.3 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
1.1 | 4.5 | GO:0048286 | lung alveolus development(GO:0048286) |
1.1 | 3.3 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
1.1 | 12.1 | GO:0034205 | beta-amyloid formation(GO:0034205) |
1.1 | 2.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
1.1 | 2.2 | GO:0051340 | regulation of ligase activity(GO:0051340) positive regulation of ligase activity(GO:0051351) |
1.1 | 24.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.1 | 17.4 | GO:0032060 | bleb assembly(GO:0032060) |
1.1 | 5.4 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
1.1 | 2.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
1.1 | 6.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.1 | 30.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.1 | 1.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
1.1 | 16.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.1 | 3.2 | GO:0061042 | vascular wound healing(GO:0061042) |
1.1 | 16.9 | GO:1901661 | quinone metabolic process(GO:1901661) |
1.1 | 2.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
1.0 | 14.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.0 | 2.1 | GO:0030242 | pexophagy(GO:0030242) |
1.0 | 1.0 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
1.0 | 1.0 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
1.0 | 10.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.0 | 3.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.0 | 15.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
1.0 | 2.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of muscle filament sliding speed(GO:0032972) |
1.0 | 9.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
1.0 | 2.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
1.0 | 1.0 | GO:0007350 | blastoderm segmentation(GO:0007350) |
1.0 | 1.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.0 | 12.9 | GO:0031648 | protein destabilization(GO:0031648) |
1.0 | 14.8 | GO:0030033 | microvillus assembly(GO:0030033) |
1.0 | 1.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
1.0 | 5.9 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
1.0 | 2.0 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
1.0 | 1.9 | GO:0010586 | miRNA metabolic process(GO:0010586) |
1.0 | 6.8 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
1.0 | 8.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.0 | 40.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
1.0 | 1.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
1.0 | 3.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.0 | 2.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 2.9 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.0 | 4.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.9 | 5.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.9 | 63.3 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.9 | 4.7 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.9 | 0.9 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.9 | 3.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.9 | 6.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.9 | 14.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.9 | 5.6 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.9 | 50.0 | GO:0006413 | translational initiation(GO:0006413) |
0.9 | 0.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.9 | 5.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.9 | 1.8 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.9 | 1.8 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.9 | 0.9 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.9 | 2.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.9 | 7.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.9 | 7.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.9 | 1.8 | GO:0070541 | response to platinum ion(GO:0070541) |
0.9 | 85.4 | GO:0070268 | cornification(GO:0070268) |
0.9 | 2.6 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.9 | 1.7 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.9 | 0.9 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.8 | 13.6 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.8 | 0.8 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.8 | 0.8 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.8 | 3.4 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.8 | 15.9 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.8 | 1.7 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.8 | 5.0 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.8 | 2.5 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.8 | 4.9 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.8 | 1.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.8 | 2.5 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.8 | 13.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.8 | 3.3 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.8 | 1.6 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.8 | 1.6 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.8 | 0.8 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.8 | 3.9 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.8 | 4.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.8 | 3.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.8 | 0.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.8 | 3.0 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.8 | 2.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 0.7 | GO:0051261 | protein depolymerization(GO:0051261) |
0.7 | 7.4 | GO:0046688 | response to copper ion(GO:0046688) |
0.7 | 5.2 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.7 | 0.7 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.7 | 4.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.7 | 0.7 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.7 | 0.7 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.7 | 11.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.7 | 11.4 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.7 | 0.7 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.7 | 30.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.7 | 0.7 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.7 | 35.6 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.7 | 1.4 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.7 | 3.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.7 | 1.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.7 | 0.7 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.7 | 2.7 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.7 | 2.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.7 | 7.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.7 | 0.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.7 | 3.3 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.6 | 3.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.6 | 13.5 | GO:0007031 | peroxisome organization(GO:0007031) |
0.6 | 3.7 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.6 | 5.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.6 | 1.8 | GO:0035803 | egg coat formation(GO:0035803) |
0.6 | 1.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.6 | 4.2 | GO:0097319 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.6 | 1.2 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.6 | 2.4 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.6 | 1.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.6 | 4.2 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.6 | 2.9 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.6 | 0.6 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.6 | 3.5 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.6 | 1.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.6 | 2.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.6 | 2.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.6 | 2.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.6 | 2.8 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 1.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 0.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.6 | 1.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.5 | 12.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 2.2 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.5 | 3.2 | GO:1990592 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.5 | 3.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.5 | 1.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.5 | 1.5 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.5 | 6.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.5 | 6.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.5 | 1.0 | GO:0050881 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.5 | 1.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.5 | 8.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.5 | 1.5 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 19.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 3.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.5 | 5.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.5 | 1.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.5 | 1.9 | GO:0032418 | lysosome localization(GO:0032418) |
0.5 | 27.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.5 | 1.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.5 | 4.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.5 | 0.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 1.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 1.4 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
0.4 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 3.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 0.9 | GO:0015791 | polyol transport(GO:0015791) |
0.4 | 1.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.4 | 1.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 3.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 1.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 58.7 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.4 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 9.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 0.4 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.4 | 1.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 5.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.4 | 6.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.4 | 13.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 8.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.4 | 2.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.4 | 3.9 | GO:0031639 | plasminogen activation(GO:0031639) |
0.4 | 26.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.4 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 0.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 4.2 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.4 | 1.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.4 | 0.4 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.4 | 0.4 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.4 | 1.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 4.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.4 | 0.4 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.4 | 0.7 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.3 | 1.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 1.0 | GO:0043584 | nose development(GO:0043584) |
0.3 | 3.4 | GO:0046129 | purine nucleoside biosynthetic process(GO:0042451) purine ribonucleoside biosynthetic process(GO:0046129) |
0.3 | 3.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.3 | 0.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.3 | GO:1901879 | regulation of protein depolymerization(GO:1901879) |
0.3 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 11.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.3 | 1.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 1.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.3 | 1.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 10.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.3 | 1.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 0.6 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.3 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 0.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 1.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 1.9 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.3 | 2.7 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.3 | 2.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 0.8 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 1.6 | GO:0032328 | alanine transport(GO:0032328) |
0.3 | 1.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 1.0 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.3 | 2.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 2.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.5 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 11.2 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.2 | 0.5 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.2 | 8.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.2 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.2 | 6.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 | 0.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 0.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 1.0 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 0.8 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 1.0 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
0.2 | 0.2 | GO:0015820 | leucine transport(GO:0015820) |
0.2 | 0.4 | GO:0002353 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.2 | 0.9 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 0.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.2 | 1.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 1.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 2.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.2 | 0.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.6 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 1.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 1.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.5 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 1.3 | GO:0006563 | L-serine metabolic process(GO:0006563) L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.6 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
0.1 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 3.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.8 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.1 | 0.2 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 1.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.1 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 0.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.2 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.1 | 0.6 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.1 | 0.2 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.1 | 0.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.7 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 2.8 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.1 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.2 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.0 | 0.1 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.2 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.0 | 1.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0097264 | self proteolysis(GO:0097264) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.8 | 103.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
24.6 | 73.8 | GO:0005960 | glycine cleavage complex(GO:0005960) |
24.4 | 122.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
23.2 | 69.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
22.6 | 112.9 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
22.2 | 88.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
21.7 | 130.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
21.6 | 64.7 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
21.3 | 213.4 | GO:0097255 | R2TP complex(GO:0097255) |
19.6 | 117.7 | GO:0071817 | MMXD complex(GO:0071817) |
18.1 | 108.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
17.8 | 53.4 | GO:0031523 | Myb complex(GO:0031523) |
16.3 | 65.2 | GO:0032301 | MutSalpha complex(GO:0032301) |
16.0 | 96.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
15.8 | 94.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
15.7 | 47.2 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
15.7 | 15.7 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
15.6 | 186.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
15.2 | 76.1 | GO:0097422 | tubular endosome(GO:0097422) |
15.0 | 74.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
14.8 | 59.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
13.9 | 69.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
13.8 | 27.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
13.6 | 136.2 | GO:0000796 | condensin complex(GO:0000796) |
13.2 | 65.8 | GO:0033503 | HULC complex(GO:0033503) |
13.2 | 236.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
13.0 | 38.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
12.6 | 88.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
12.5 | 12.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
12.4 | 99.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
12.2 | 36.7 | GO:0044393 | microspike(GO:0044393) |
12.2 | 36.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
12.2 | 12.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
12.2 | 85.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
12.1 | 157.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
11.7 | 152.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
11.6 | 46.3 | GO:0000811 | GINS complex(GO:0000811) |
11.5 | 57.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
11.4 | 11.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
11.2 | 302.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
11.2 | 67.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
10.9 | 54.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
10.7 | 160.9 | GO:0090543 | Flemming body(GO:0090543) |
10.6 | 63.5 | GO:0005683 | U7 snRNP(GO:0005683) |
10.5 | 52.7 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
10.5 | 105.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
10.3 | 93.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
10.3 | 10.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
10.3 | 195.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
10.3 | 61.7 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
10.3 | 51.3 | GO:0032021 | NELF complex(GO:0032021) |
10.2 | 40.9 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
10.2 | 61.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
10.2 | 30.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
10.1 | 111.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
9.9 | 49.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
9.9 | 39.6 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
9.9 | 118.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
9.7 | 68.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
9.6 | 76.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
9.6 | 47.8 | GO:0070938 | contractile ring(GO:0070938) |
9.5 | 38.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
9.5 | 85.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
9.4 | 94.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
9.4 | 47.0 | GO:0070470 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
9.3 | 28.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
9.2 | 36.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
9.0 | 36.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
8.9 | 88.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
8.8 | 96.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
8.7 | 165.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
8.6 | 25.8 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
8.6 | 77.4 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
8.6 | 85.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
8.6 | 51.4 | GO:0001740 | Barr body(GO:0001740) |
8.6 | 94.2 | GO:0034709 | methylosome(GO:0034709) |
8.5 | 94.0 | GO:0005688 | U6 snRNP(GO:0005688) |
8.5 | 59.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
8.5 | 42.7 | GO:0001940 | male pronucleus(GO:0001940) |
8.5 | 68.3 | GO:0042382 | paraspeckles(GO:0042382) |
8.5 | 33.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
8.4 | 42.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
8.4 | 67.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
8.3 | 58.3 | GO:0016589 | NURF complex(GO:0016589) |
8.3 | 8.3 | GO:1990246 | uniplex complex(GO:1990246) |
8.3 | 41.4 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
8.2 | 24.6 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
8.2 | 24.5 | GO:0097441 | basilar dendrite(GO:0097441) |
8.0 | 47.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
7.9 | 110.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
7.8 | 39.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
7.8 | 101.6 | GO:0005916 | fascia adherens(GO:0005916) |
7.8 | 54.6 | GO:0031415 | NatA complex(GO:0031415) |
7.8 | 23.3 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
7.7 | 145.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
7.6 | 38.0 | GO:0071797 | LUBAC complex(GO:0071797) |
7.6 | 22.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
7.5 | 60.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
7.5 | 52.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
7.5 | 22.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
7.4 | 37.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
7.3 | 308.3 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
7.3 | 7.3 | GO:0005687 | U4 snRNP(GO:0005687) |
7.2 | 50.7 | GO:0016272 | prefoldin complex(GO:0016272) |
7.1 | 70.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
7.0 | 210.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
7.0 | 55.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
7.0 | 167.0 | GO:0071564 | npBAF complex(GO:0071564) |
6.9 | 27.7 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
6.9 | 124.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
6.8 | 6.8 | GO:0044308 | axonal spine(GO:0044308) |
6.7 | 33.5 | GO:0032449 | CBM complex(GO:0032449) |
6.7 | 26.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
6.6 | 79.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
6.6 | 13.2 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
6.6 | 46.1 | GO:0071203 | WASH complex(GO:0071203) |
6.6 | 52.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
6.6 | 190.8 | GO:0000502 | proteasome complex(GO:0000502) |
6.6 | 72.1 | GO:0016600 | flotillin complex(GO:0016600) |
6.5 | 51.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
6.5 | 90.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
6.4 | 25.7 | GO:0070552 | BRISC complex(GO:0070552) |
6.4 | 6.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
6.2 | 43.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
6.2 | 24.9 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
6.2 | 37.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
6.1 | 6.1 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
6.1 | 18.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
6.1 | 54.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
6.0 | 186.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
6.0 | 162.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
6.0 | 12.0 | GO:0030689 | Noc complex(GO:0030689) |
6.0 | 24.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
6.0 | 77.5 | GO:0042555 | MCM complex(GO:0042555) |
6.0 | 41.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
5.9 | 47.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
5.9 | 23.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
5.9 | 76.3 | GO:0097470 | ribbon synapse(GO:0097470) |
5.9 | 123.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
5.8 | 93.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
5.8 | 5.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
5.8 | 17.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
5.6 | 78.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
5.6 | 61.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
5.6 | 941.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
5.5 | 77.5 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
5.5 | 65.9 | GO:0030008 | TRAPP complex(GO:0030008) |
5.5 | 27.4 | GO:0097452 | GAIT complex(GO:0097452) |
5.5 | 27.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
5.4 | 277.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
5.4 | 16.3 | GO:0045180 | basal cortex(GO:0045180) |
5.4 | 32.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
5.3 | 101.6 | GO:0036020 | endolysosome membrane(GO:0036020) |
5.3 | 37.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
5.3 | 698.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
5.3 | 68.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
5.2 | 192.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
5.2 | 15.6 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
5.2 | 57.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
5.1 | 51.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
5.1 | 10.3 | GO:1990423 | RZZ complex(GO:1990423) |
5.1 | 77.0 | GO:0032433 | filopodium tip(GO:0032433) |
5.1 | 15.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
5.1 | 10.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
5.0 | 25.2 | GO:0071986 | Ragulator complex(GO:0071986) |
5.0 | 15.1 | GO:0018444 | translation release factor complex(GO:0018444) |
5.0 | 115.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
5.0 | 34.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
5.0 | 24.8 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
4.9 | 49.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
4.9 | 29.4 | GO:0031012 | extracellular matrix(GO:0031012) |
4.9 | 4.9 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
4.9 | 68.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
4.9 | 102.5 | GO:0031143 | pseudopodium(GO:0031143) |
4.8 | 43.3 | GO:0005638 | lamin filament(GO:0005638) |
4.8 | 28.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
4.8 | 4.8 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
4.8 | 14.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
4.7 | 66.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
4.7 | 18.9 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
4.7 | 112.1 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
4.6 | 13.9 | GO:0043291 | RAVE complex(GO:0043291) |
4.6 | 41.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
4.6 | 32.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
4.6 | 86.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
4.5 | 222.5 | GO:0043034 | costamere(GO:0043034) |
4.5 | 9.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
4.4 | 30.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
4.4 | 4.4 | GO:0036452 | ESCRT complex(GO:0036452) |
4.3 | 17.3 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
4.3 | 34.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
4.3 | 4.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
4.3 | 12.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
4.2 | 8.4 | GO:1990357 | terminal web(GO:1990357) |
4.2 | 25.2 | GO:0005915 | zonula adherens(GO:0005915) |
4.2 | 371.7 | GO:0070469 | respiratory chain(GO:0070469) |
4.2 | 20.9 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
4.2 | 12.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
4.1 | 33.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
4.1 | 12.3 | GO:1902636 | kinociliary basal body(GO:1902636) |
4.1 | 8.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
4.0 | 12.0 | GO:0034455 | t-UTP complex(GO:0034455) |
4.0 | 43.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
4.0 | 51.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
4.0 | 4.0 | GO:0005771 | multivesicular body(GO:0005771) |
3.9 | 11.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
3.8 | 26.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
3.8 | 3.8 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
3.8 | 3.8 | GO:0035061 | interchromatin granule(GO:0035061) |
3.7 | 11.1 | GO:0072563 | endothelial microparticle(GO:0072563) |
3.7 | 18.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
3.7 | 14.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
3.7 | 25.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
3.7 | 11.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
3.6 | 7.3 | GO:0043260 | laminin-11 complex(GO:0043260) |
3.6 | 3.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
3.6 | 28.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
3.6 | 28.7 | GO:0044754 | autolysosome(GO:0044754) |
3.6 | 21.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
3.6 | 10.7 | GO:0071159 | NF-kappaB complex(GO:0071159) |
3.5 | 10.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
3.5 | 14.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.5 | 45.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
3.5 | 79.8 | GO:0005685 | U1 snRNP(GO:0005685) |
3.5 | 72.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
3.5 | 24.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
3.4 | 20.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
3.4 | 3.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
3.4 | 6.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
3.4 | 10.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
3.4 | 50.5 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
3.3 | 43.5 | GO:0005869 | dynactin complex(GO:0005869) |
3.3 | 147.0 | GO:0005876 | spindle microtubule(GO:0005876) |
3.3 | 3.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
3.3 | 13.2 | GO:0031673 | H zone(GO:0031673) |
3.3 | 13.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
3.3 | 16.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
3.2 | 12.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
3.2 | 6.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
3.2 | 1735.9 | GO:0005925 | focal adhesion(GO:0005925) |
3.2 | 22.4 | GO:0042641 | actomyosin(GO:0042641) |
3.2 | 12.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
3.2 | 22.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
3.1 | 56.6 | GO:0070822 | Sin3-type complex(GO:0070822) |
3.1 | 9.4 | GO:0044295 | axonal growth cone(GO:0044295) |
3.1 | 18.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
3.1 | 9.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
3.1 | 111.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
3.1 | 9.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
3.1 | 159.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
3.1 | 6.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
3.0 | 27.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
3.0 | 12.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
3.0 | 9.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
3.0 | 18.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
3.0 | 9.0 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
3.0 | 45.0 | GO:1990752 | microtubule end(GO:1990752) |
3.0 | 35.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
3.0 | 32.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
3.0 | 9.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
3.0 | 209.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
2.9 | 17.6 | GO:0030677 | ribonuclease P complex(GO:0030677) |
2.9 | 49.9 | GO:0044391 | ribosomal subunit(GO:0044391) |
2.9 | 11.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
2.9 | 5.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
2.9 | 8.6 | GO:1990393 | 3M complex(GO:1990393) |
2.8 | 45.5 | GO:0000812 | Swr1 complex(GO:0000812) |
2.8 | 11.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
2.8 | 19.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
2.8 | 16.8 | GO:0000124 | SAGA complex(GO:0000124) |
2.8 | 160.2 | GO:0031970 | organelle envelope lumen(GO:0031970) |
2.8 | 5.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
2.7 | 32.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
2.7 | 18.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
2.6 | 7.9 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.6 | 2.6 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
2.6 | 23.6 | GO:0005955 | calcineurin complex(GO:0005955) |
2.6 | 26.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.6 | 7.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.6 | 15.5 | GO:0016363 | nuclear matrix(GO:0016363) |
2.6 | 444.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
2.5 | 30.6 | GO:0090544 | BAF-type complex(GO:0090544) |
2.5 | 12.7 | GO:0030894 | replisome(GO:0030894) |
2.5 | 22.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
2.5 | 27.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
2.5 | 39.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
2.5 | 12.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
2.5 | 14.7 | GO:0061574 | ASAP complex(GO:0061574) |
2.4 | 149.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
2.4 | 26.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.4 | 16.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.4 | 7.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.3 | 74.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
2.3 | 2.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
2.3 | 29.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
2.3 | 13.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
2.2 | 8.9 | GO:0032044 | DSIF complex(GO:0032044) |
2.2 | 11.0 | GO:0001739 | sex chromatin(GO:0001739) |
2.2 | 15.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
2.2 | 19.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
2.1 | 23.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
2.1 | 21.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
2.1 | 21.0 | GO:0031209 | SCAR complex(GO:0031209) |
2.1 | 37.6 | GO:0097342 | ripoptosome(GO:0097342) |
2.1 | 41.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
2.1 | 18.6 | GO:0005614 | interstitial matrix(GO:0005614) |
2.1 | 4.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
2.0 | 30.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
2.0 | 8.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
2.0 | 47.9 | GO:0005861 | troponin complex(GO:0005861) |
2.0 | 15.7 | GO:0005642 | annulate lamellae(GO:0005642) |
1.9 | 9.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.9 | 1.9 | GO:1990462 | omegasome(GO:1990462) |
1.9 | 5.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.9 | 3.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.9 | 11.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
1.9 | 81.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.9 | 5.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.9 | 575.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.9 | 14.8 | GO:0070652 | HAUS complex(GO:0070652) |
1.8 | 107.0 | GO:0005811 | lipid particle(GO:0005811) |
1.8 | 7.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.8 | 9.0 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
1.8 | 14.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.8 | 75.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.8 | 5.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
1.8 | 5.3 | GO:0097447 | dendritic tree(GO:0097447) |
1.7 | 3.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.7 | 63.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
1.7 | 116.8 | GO:0000776 | kinetochore(GO:0000776) |
1.7 | 73.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.7 | 1.7 | GO:0000803 | sex chromosome(GO:0000803) |
1.7 | 56.4 | GO:0031526 | brush border membrane(GO:0031526) |
1.7 | 32.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
1.7 | 40.5 | GO:0045178 | basal part of cell(GO:0045178) |
1.7 | 10.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.7 | 1.7 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
1.7 | 6.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.6 | 1.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.6 | 86.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.6 | 141.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
1.6 | 14.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.6 | 1.6 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
1.6 | 64.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.6 | 15.5 | GO:0070187 | telosome(GO:0070187) |
1.6 | 26.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.5 | 1.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.5 | 3.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
1.5 | 16.8 | GO:0097346 | INO80-type complex(GO:0097346) |
1.5 | 93.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.5 | 13.5 | GO:0032059 | bleb(GO:0032059) |
1.5 | 11.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
1.5 | 13.3 | GO:0030904 | retromer complex(GO:0030904) |
1.4 | 27.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.4 | 30.4 | GO:0001726 | ruffle(GO:0001726) |
1.4 | 1.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.4 | 2.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.4 | 8.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.4 | 6.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.4 | 6.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.4 | 2.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.4 | 1.4 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
1.3 | 21.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.3 | 13.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
1.3 | 3.9 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
1.3 | 30.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.3 | 56.0 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
1.3 | 1.3 | GO:0097386 | glial cell projection(GO:0097386) |
1.2 | 17.5 | GO:0031932 | TORC2 complex(GO:0031932) |
1.2 | 4.9 | GO:0000346 | transcription export complex(GO:0000346) |
1.2 | 12.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.2 | 20.8 | GO:0032432 | actin filament bundle(GO:0032432) |
1.2 | 6.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
1.2 | 23.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.2 | 6.1 | GO:0005903 | brush border(GO:0005903) |
1.2 | 58.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.2 | 3.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.2 | 25.3 | GO:0035580 | specific granule lumen(GO:0035580) |
1.2 | 24.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
1.2 | 8.2 | GO:0032039 | integrator complex(GO:0032039) |
1.2 | 2831.1 | GO:0070062 | extracellular exosome(GO:0070062) |
1.1 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
1.1 | 7.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.1 | 7.5 | GO:0070852 | cell body fiber(GO:0070852) |
1.0 | 4.0 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
1.0 | 1.0 | GO:1990745 | GARP complex(GO:0000938) EARP complex(GO:1990745) |
1.0 | 5.8 | GO:1990635 | proximal dendrite(GO:1990635) |
1.0 | 3.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.9 | 12.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.9 | 1.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.9 | 29.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.9 | 1.8 | GO:0055087 | Ski complex(GO:0055087) |
0.9 | 12.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.9 | 1.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.8 | 1.7 | GO:0043203 | axon hillock(GO:0043203) |
0.8 | 0.8 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.8 | 8.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule membrane(GO:0035577) azurophil granule(GO:0042582) |
0.8 | 1.5 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.7 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.7 | 1.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.6 | 28.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.6 | 0.6 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.6 | 2.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.6 | 3.5 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.6 | 3.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.6 | 1.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 3.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 5.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 6.3 | GO:0005814 | centriole(GO:0005814) |
0.5 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 30.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.5 | 1.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
0.5 | 22.8 | GO:0005901 | caveola(GO:0005901) |
0.5 | 0.9 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.5 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.5 | 15.9 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 2.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.4 | 3.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 1.3 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.4 | 1.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.4 | 109.9 | GO:0005635 | nuclear envelope(GO:0005635) |
0.4 | 9.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.4 | 0.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 2.7 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 11.0 | GO:0005840 | ribosome(GO:0005840) |
0.4 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.4 | 2.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 3.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.3 | 1.7 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 4.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 2.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 8.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 1.1 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.3 | 0.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) junctional membrane complex(GO:0030314) |
0.3 | 9.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 27.7 | GO:0005819 | spindle(GO:0005819) |
0.2 | 8.6 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 7.6 | GO:0035579 | specific granule membrane(GO:0035579) |
0.2 | 4.5 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 11.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 4.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.0 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.0 | GO:0016938 | kinesin I complex(GO:0016938) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
46.2 | 184.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
33.7 | 101.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
27.4 | 164.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
25.2 | 126.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
24.4 | 73.2 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
23.3 | 93.2 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
23.0 | 161.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
22.7 | 68.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
22.2 | 88.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
21.8 | 108.9 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
21.8 | 152.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
21.3 | 106.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
20.7 | 62.0 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
20.0 | 80.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
20.0 | 180.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
19.8 | 59.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
19.8 | 138.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
19.5 | 78.0 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
19.5 | 77.9 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
19.4 | 77.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
18.7 | 74.9 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
18.4 | 91.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
17.5 | 52.6 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
16.8 | 16.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
16.3 | 65.2 | GO:0032143 | single thymine insertion binding(GO:0032143) |
16.1 | 16.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
16.0 | 47.9 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
15.9 | 63.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
15.8 | 63.3 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
15.8 | 94.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
15.7 | 125.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
15.6 | 156.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
15.5 | 77.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
15.3 | 45.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
15.3 | 61.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
14.9 | 44.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
14.8 | 44.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
14.8 | 59.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
14.6 | 87.9 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
14.6 | 43.9 | GO:0004797 | thymidine kinase activity(GO:0004797) |
14.6 | 58.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
14.6 | 87.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
14.5 | 130.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
14.5 | 29.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
14.2 | 85.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
14.0 | 42.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
13.9 | 97.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
13.9 | 55.6 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
13.9 | 111.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
13.7 | 54.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
13.6 | 40.7 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
13.6 | 40.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
13.2 | 39.6 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
13.2 | 236.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
13.1 | 157.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
13.0 | 51.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
12.8 | 77.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
12.8 | 38.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
12.7 | 50.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
12.7 | 38.0 | GO:0004766 | spermidine synthase activity(GO:0004766) |
12.6 | 113.0 | GO:0015288 | porin activity(GO:0015288) |
12.6 | 37.7 | GO:0098809 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
12.4 | 148.5 | GO:0031386 | protein tag(GO:0031386) |
12.3 | 86.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
12.2 | 85.7 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
12.2 | 48.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
12.2 | 36.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
12.1 | 60.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
12.0 | 72.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
12.0 | 36.0 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
11.9 | 47.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
11.8 | 35.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
11.7 | 46.7 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
11.6 | 162.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
11.5 | 34.5 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
11.4 | 68.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
11.3 | 56.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
11.2 | 33.5 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
11.1 | 44.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
10.9 | 328.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
10.9 | 43.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
10.8 | 32.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
10.8 | 32.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
10.7 | 42.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
10.3 | 31.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
10.3 | 61.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
10.2 | 30.7 | GO:0003883 | CTP synthase activity(GO:0003883) |
10.2 | 40.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
10.1 | 10.1 | GO:0019956 | chemokine binding(GO:0019956) |
10.1 | 40.2 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
10.0 | 100.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
10.0 | 30.0 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
10.0 | 49.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
9.9 | 39.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
9.8 | 48.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
9.7 | 9.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
9.6 | 38.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
9.5 | 409.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
9.4 | 28.3 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
9.4 | 65.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
9.4 | 178.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
9.4 | 9.4 | GO:0004175 | endopeptidase activity(GO:0004175) |
9.3 | 18.7 | GO:0016531 | copper chaperone activity(GO:0016531) |
9.3 | 46.5 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
9.2 | 36.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
9.0 | 72.3 | GO:0005497 | androgen binding(GO:0005497) |
9.0 | 53.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
9.0 | 26.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
9.0 | 35.8 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
8.9 | 44.7 | GO:0070404 | NADH binding(GO:0070404) |
8.9 | 44.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
8.9 | 17.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
8.8 | 106.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
8.8 | 26.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
8.8 | 96.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
8.6 | 171.9 | GO:0070628 | proteasome binding(GO:0070628) |
8.6 | 59.9 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
8.5 | 110.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
8.5 | 25.4 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
8.5 | 25.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
8.3 | 16.6 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
8.3 | 57.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
8.3 | 8.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
8.2 | 32.7 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
8.1 | 24.3 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
8.1 | 48.6 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
8.0 | 24.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
8.0 | 32.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
8.0 | 31.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
8.0 | 79.7 | GO:0042731 | PH domain binding(GO:0042731) |
7.9 | 39.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
7.9 | 39.4 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
7.9 | 7.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
7.8 | 15.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
7.8 | 210.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
7.6 | 22.8 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
7.6 | 22.7 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
7.5 | 60.2 | GO:0030911 | TPR domain binding(GO:0030911) |
7.5 | 29.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
7.3 | 7.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
7.3 | 51.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
7.3 | 65.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
7.3 | 334.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
7.2 | 21.7 | GO:0030984 | kininogen binding(GO:0030984) |
7.2 | 36.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
7.2 | 21.6 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
7.2 | 78.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
7.1 | 28.3 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
7.1 | 92.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
7.1 | 28.3 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
7.1 | 7.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
7.1 | 70.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
7.0 | 28.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
7.0 | 28.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
7.0 | 27.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
6.8 | 47.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
6.8 | 33.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
6.7 | 40.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
6.6 | 92.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
6.6 | 33.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
6.6 | 26.4 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
6.6 | 59.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
6.6 | 19.7 | GO:0032427 | GBD domain binding(GO:0032427) |
6.4 | 38.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
6.4 | 31.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
6.4 | 44.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
6.4 | 19.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
6.3 | 19.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
6.3 | 31.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
6.3 | 50.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
6.2 | 18.7 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
6.2 | 62.4 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
6.2 | 37.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
6.2 | 6.2 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
6.2 | 24.8 | GO:0016936 | galactoside binding(GO:0016936) |
6.2 | 24.7 | GO:0043515 | kinetochore binding(GO:0043515) |
6.2 | 18.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
6.1 | 18.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
6.1 | 109.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
6.1 | 24.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
6.1 | 48.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
6.1 | 12.1 | GO:0043398 | HLH domain binding(GO:0043398) |
6.0 | 30.2 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
6.0 | 12.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
6.0 | 59.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
6.0 | 101.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
6.0 | 11.9 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
5.9 | 146.5 | GO:0017166 | vinculin binding(GO:0017166) |
5.8 | 11.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
5.8 | 46.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
5.8 | 52.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
5.8 | 69.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
5.8 | 225.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
5.8 | 17.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
5.8 | 132.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
5.7 | 86.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
5.7 | 194.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
5.7 | 11.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
5.7 | 17.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
5.7 | 11.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
5.7 | 33.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
5.6 | 16.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
5.6 | 112.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
5.6 | 50.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
5.6 | 88.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
5.5 | 122.0 | GO:0000339 | RNA cap binding(GO:0000339) |
5.5 | 16.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
5.5 | 11.0 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
5.5 | 27.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
5.5 | 11.0 | GO:0046979 | TAP2 binding(GO:0046979) |
5.5 | 11.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
5.5 | 16.5 | GO:0048030 | disaccharide binding(GO:0048030) |
5.5 | 22.0 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
5.5 | 27.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
5.5 | 16.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
5.5 | 16.4 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
5.5 | 43.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
5.4 | 59.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
5.4 | 21.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
5.4 | 5.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
5.4 | 16.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
5.3 | 42.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
5.3 | 26.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
5.3 | 79.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
5.3 | 21.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
5.3 | 53.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
5.3 | 370.1 | GO:0019003 | GDP binding(GO:0019003) |
5.2 | 15.7 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
5.2 | 246.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
5.2 | 47.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
5.2 | 5.2 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
5.2 | 20.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
5.1 | 10.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
5.1 | 15.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
5.1 | 10.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
5.1 | 10.2 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
5.1 | 35.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
5.1 | 55.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
5.0 | 25.2 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
5.0 | 211.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
5.0 | 15.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
5.0 | 35.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
5.0 | 40.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
5.0 | 20.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
5.0 | 19.9 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
5.0 | 44.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
5.0 | 59.7 | GO:0089720 | caspase binding(GO:0089720) |
4.9 | 39.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
4.9 | 78.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
4.9 | 29.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
4.8 | 159.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
4.8 | 33.9 | GO:0070990 | snRNP binding(GO:0070990) |
4.8 | 24.2 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
4.8 | 33.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
4.8 | 9.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
4.8 | 67.1 | GO:0031014 | troponin T binding(GO:0031014) |
4.8 | 23.9 | GO:0070513 | death domain binding(GO:0070513) |
4.8 | 28.6 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
4.8 | 28.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
4.8 | 9.5 | GO:0070026 | nitric oxide binding(GO:0070026) |
4.7 | 47.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
4.7 | 42.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
4.7 | 14.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
4.7 | 23.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
4.7 | 23.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
4.6 | 115.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
4.5 | 18.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
4.5 | 13.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
4.5 | 45.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
4.4 | 1878.1 | GO:0045296 | cadherin binding(GO:0045296) |
4.4 | 4.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
4.4 | 53.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
4.4 | 128.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
4.4 | 13.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
4.4 | 127.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
4.4 | 123.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
4.4 | 26.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
4.3 | 34.8 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
4.3 | 69.4 | GO:0008494 | translation activator activity(GO:0008494) |
4.3 | 21.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
4.3 | 8.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
4.3 | 25.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
4.2 | 34.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
4.2 | 21.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
4.2 | 79.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
4.2 | 25.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
4.2 | 20.9 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
4.2 | 8.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
4.1 | 24.8 | GO:0036310 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
4.1 | 65.8 | GO:0008143 | poly(A) binding(GO:0008143) |
4.1 | 12.3 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
4.1 | 12.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
4.1 | 12.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
4.1 | 20.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
4.0 | 16.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
4.0 | 16.2 | GO:1903135 | cupric ion binding(GO:1903135) |
4.0 | 116.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
4.0 | 12.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
4.0 | 12.1 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
4.0 | 8.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
4.0 | 11.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
3.9 | 11.8 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
3.9 | 3.9 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
3.9 | 19.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
3.9 | 15.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
3.9 | 7.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
3.9 | 11.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
3.9 | 27.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
3.9 | 27.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
3.8 | 11.5 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
3.8 | 111.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
3.8 | 23.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
3.8 | 705.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
3.8 | 22.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
3.7 | 82.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
3.7 | 11.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
3.7 | 14.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
3.7 | 29.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
3.7 | 11.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
3.6 | 10.8 | GO:0034046 | poly(G) binding(GO:0034046) |
3.6 | 14.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.6 | 18.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
3.6 | 14.4 | GO:0004335 | galactokinase activity(GO:0004335) |
3.6 | 3.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
3.6 | 14.2 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
3.6 | 7.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
3.5 | 17.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
3.5 | 67.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
3.5 | 49.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
3.5 | 10.5 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
3.5 | 27.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
3.5 | 13.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
3.5 | 10.4 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
3.4 | 20.7 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
3.4 | 75.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
3.4 | 13.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
3.4 | 6.8 | GO:0031996 | thioesterase binding(GO:0031996) |
3.4 | 88.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
3.4 | 122.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
3.4 | 37.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
3.4 | 13.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
3.4 | 10.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
3.4 | 6.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
3.4 | 6.8 | GO:0019239 | deaminase activity(GO:0019239) |
3.4 | 20.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
3.4 | 6.7 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
3.4 | 3.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
3.3 | 23.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
3.3 | 46.6 | GO:0031402 | sodium ion binding(GO:0031402) |
3.3 | 149.2 | GO:0050699 | WW domain binding(GO:0050699) |
3.3 | 76.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
3.3 | 23.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
3.3 | 6.6 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
3.3 | 16.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
3.3 | 6.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
3.3 | 65.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
3.2 | 22.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
3.2 | 9.7 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
3.2 | 42.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
3.2 | 12.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
3.2 | 90.2 | GO:0005123 | death receptor binding(GO:0005123) |
3.2 | 22.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
3.2 | 12.9 | GO:0036033 | mediator complex binding(GO:0036033) |
3.2 | 6.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
3.2 | 19.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
3.2 | 159.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
3.2 | 3.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
3.2 | 25.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
3.2 | 34.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
3.2 | 6.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
3.1 | 401.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
3.1 | 15.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
3.1 | 43.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
3.1 | 37.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
3.1 | 40.0 | GO:0043295 | glutathione binding(GO:0043295) |
3.1 | 9.2 | GO:0031491 | nucleosome binding(GO:0031491) |
3.1 | 55.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
3.1 | 3.1 | GO:0032810 | sterol response element binding(GO:0032810) |
3.1 | 30.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
3.0 | 9.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
3.0 | 15.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
3.0 | 9.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
3.0 | 21.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
3.0 | 9.0 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
3.0 | 14.9 | GO:0004064 | arylesterase activity(GO:0004064) |
3.0 | 8.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
3.0 | 23.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
2.9 | 20.5 | GO:0070402 | NADPH binding(GO:0070402) |
2.9 | 29.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.9 | 5.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
2.9 | 14.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
2.9 | 37.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
2.9 | 55.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
2.9 | 5.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.9 | 114.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
2.9 | 11.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
2.9 | 14.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
2.8 | 42.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
2.8 | 8.5 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
2.8 | 22.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
2.8 | 11.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
2.8 | 98.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
2.8 | 5.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
2.8 | 45.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.8 | 78.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
2.8 | 8.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
2.8 | 2.8 | GO:0046790 | virion binding(GO:0046790) |
2.8 | 5.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
2.8 | 5.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.7 | 16.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.7 | 30.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.7 | 8.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
2.7 | 78.6 | GO:0051287 | NAD binding(GO:0051287) |
2.7 | 37.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
2.7 | 10.8 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
2.7 | 43.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
2.7 | 8.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
2.7 | 8.1 | GO:0000150 | recombinase activity(GO:0000150) |
2.7 | 8.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.7 | 2.7 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
2.7 | 47.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.6 | 47.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
2.6 | 15.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
2.6 | 7.8 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
2.6 | 36.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.6 | 25.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
2.6 | 7.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.5 | 89.0 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
2.5 | 20.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.5 | 2.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
2.5 | 7.5 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
2.5 | 35.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.5 | 10.0 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
2.5 | 37.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
2.5 | 7.5 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
2.5 | 19.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.5 | 4.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.5 | 71.3 | GO:0004386 | helicase activity(GO:0004386) |
2.5 | 49.1 | GO:0051400 | BH domain binding(GO:0051400) |
2.5 | 7.4 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
2.4 | 41.5 | GO:0008483 | transaminase activity(GO:0008483) |
2.4 | 4.9 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
2.4 | 82.7 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
2.4 | 9.7 | GO:0002046 | opsin binding(GO:0002046) |
2.4 | 12.1 | GO:0038064 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
2.4 | 9.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
2.4 | 2.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
2.4 | 16.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.4 | 33.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.4 | 21.2 | GO:1901567 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
2.4 | 4.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
2.3 | 28.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
2.3 | 2.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
2.3 | 32.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.3 | 30.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
2.2 | 11.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
2.2 | 117.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
2.2 | 11.0 | GO:0097016 | L27 domain binding(GO:0097016) |
2.2 | 78.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
2.2 | 6.5 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
2.2 | 17.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
2.2 | 122.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
2.2 | 21.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
2.2 | 10.8 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
2.1 | 117.9 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
2.1 | 27.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.1 | 70.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
2.1 | 14.8 | GO:0000182 | rDNA binding(GO:0000182) |
2.1 | 46.4 | GO:0035326 | enhancer binding(GO:0035326) |
2.1 | 2.1 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
2.1 | 10.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.1 | 4.2 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
2.1 | 12.4 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
2.1 | 22.7 | GO:0044548 | S100 protein binding(GO:0044548) |
2.1 | 22.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
2.1 | 14.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
2.0 | 8.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
2.0 | 18.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
2.0 | 14.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
2.0 | 2.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
2.0 | 8.0 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
2.0 | 4.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
2.0 | 2.0 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
2.0 | 121.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
2.0 | 9.8 | GO:0016301 | kinase activity(GO:0016301) |
2.0 | 7.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
2.0 | 5.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.9 | 19.5 | GO:0003680 | AT DNA binding(GO:0003680) |
1.9 | 40.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.9 | 9.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.9 | 9.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.9 | 102.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.9 | 5.8 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.9 | 1.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.9 | 19.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.9 | 15.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.9 | 45.9 | GO:0015248 | sterol transporter activity(GO:0015248) |
1.9 | 13.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.9 | 9.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.9 | 11.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.9 | 7.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.9 | 1.9 | GO:0008199 | ferric iron binding(GO:0008199) |
1.9 | 18.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.9 | 9.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.8 | 11.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
1.8 | 5.5 | GO:0032089 | NACHT domain binding(GO:0032089) |
1.8 | 3.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.8 | 3.7 | GO:0030552 | cAMP binding(GO:0030552) |
1.8 | 3.7 | GO:0043532 | angiostatin binding(GO:0043532) |
1.8 | 5.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
1.8 | 19.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.8 | 23.3 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
1.8 | 10.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
1.8 | 277.5 | GO:0005178 | integrin binding(GO:0005178) |
1.8 | 68.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.7 | 7.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.7 | 25.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
1.7 | 23.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.7 | 8.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.7 | 5.1 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.7 | 13.5 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
1.7 | 23.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.6 | 32.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.6 | 6.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
1.6 | 3.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.6 | 59.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
1.6 | 9.4 | GO:0051425 | PTB domain binding(GO:0051425) |
1.6 | 18.7 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
1.5 | 3.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.5 | 101.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
1.5 | 119.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
1.5 | 56.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
1.5 | 7.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.5 | 29.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.5 | 8.8 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
1.5 | 4.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
1.5 | 16.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.5 | 7.3 | GO:0016015 | morphogen activity(GO:0016015) |
1.4 | 4.3 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
1.4 | 10.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
1.4 | 14.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.4 | 5.6 | GO:0015266 | protein channel activity(GO:0015266) |
1.4 | 92.1 | GO:0008565 | protein transporter activity(GO:0008565) |
1.4 | 2.7 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
1.3 | 60.6 | GO:0005507 | copper ion binding(GO:0005507) |
1.3 | 35.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.3 | 17.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.3 | 10.5 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.3 | 3.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.3 | 3.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.3 | 5.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.3 | 5.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
1.2 | 2.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.2 | 3.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.2 | 3.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.2 | 6.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.2 | 4.7 | GO:0015350 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
1.2 | 10.6 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
1.2 | 2.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.2 | 17.6 | GO:0005537 | mannose binding(GO:0005537) |
1.2 | 2.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
1.2 | 28.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.2 | 11.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.1 | 75.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.1 | 8.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
1.1 | 4.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.1 | 18.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.1 | 3.4 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
1.1 | 7.6 | GO:0052723 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.1 | 5.4 | GO:0043531 | ADP binding(GO:0043531) |
1.1 | 8.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
1.1 | 2.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
1.1 | 9.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
1.1 | 17.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
1.1 | 28.6 | GO:0015485 | cholesterol binding(GO:0015485) |
1.1 | 4.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
1.0 | 6.2 | GO:0019863 | IgE binding(GO:0019863) |
1.0 | 13.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.0 | 5.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.0 | 1.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.0 | 8.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.0 | 180.0 | GO:0003924 | GTPase activity(GO:0003924) |
1.0 | 5.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.0 | 32.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.0 | 2.9 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.0 | 6.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.9 | 3.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.9 | 35.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.9 | 23.6 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.9 | 10.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.9 | 3.7 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.9 | 4.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.9 | 0.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.9 | 3.7 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.9 | 6.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.9 | 10.7 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.9 | 0.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.9 | 0.9 | GO:0052811 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.9 | 5.3 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.9 | 9.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.9 | 4.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.8 | 1.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 95.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.8 | 7.6 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.8 | 2.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.8 | 4.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.8 | 863.2 | GO:0003723 | RNA binding(GO:0003723) |
0.8 | 0.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.8 | 3.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 3.9 | GO:0033265 | choline binding(GO:0033265) |
0.8 | 14.8 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.8 | 12.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.8 | 1.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.8 | 3.8 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.8 | 3.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 1.5 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.7 | 2.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 10.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.7 | 1.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.7 | 2.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.7 | 5.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.7 | 4.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.7 | 0.7 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 3.8 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.6 | 4.2 | GO:0070061 | fructose binding(GO:0070061) |
0.6 | 12.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.6 | 2.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.6 | 27.6 | GO:0005496 | steroid binding(GO:0005496) |
0.6 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 9.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.5 | 2.1 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.5 | 1.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.5 | 1.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.5 | 1.4 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.4 | 4.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.4 | 3.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.4 | 8.1 | GO:0016829 | lyase activity(GO:0016829) |
0.4 | 4.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.4 | 2.8 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 1.2 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.4 | 1.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 5.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.4 | 0.4 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.4 | 2.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 5.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 1.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 4.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 4.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 2.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 0.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 2.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.3 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.3 | 0.5 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.3 | 0.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.2 | 4.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 1.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 4.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 3.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.2 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.7 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 0.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.2 | 0.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 7.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 2.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 69.0 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 0.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 4.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.5 | GO:0005254 | chloride channel activity(GO:0005254) |
0.2 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 4.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 2.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.6 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 2.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.5 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 1.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 2.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.2 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 0.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.4 | 146.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
7.9 | 323.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
7.8 | 1088.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
6.7 | 322.0 | PID BARD1 PATHWAY | BARD1 signaling events |
6.3 | 189.9 | PID ATR PATHWAY | ATR signaling pathway |
6.0 | 317.5 | PID AURORA B PATHWAY | Aurora B signaling |
6.0 | 191.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
5.9 | 5.9 | PID MYC PATHWAY | C-MYC pathway |
5.7 | 319.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
5.2 | 15.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
5.1 | 111.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
5.0 | 190.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
4.8 | 225.1 | PID PLK1 PATHWAY | PLK1 signaling events |
4.7 | 309.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
4.5 | 9.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
4.4 | 100.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
4.2 | 181.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
4.2 | 354.5 | PID E2F PATHWAY | E2F transcription factor network |
4.1 | 295.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
3.8 | 15.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
3.6 | 69.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
3.6 | 64.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
3.3 | 76.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
3.0 | 190.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
2.9 | 43.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.9 | 46.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.8 | 48.0 | PID AURORA A PATHWAY | Aurora A signaling |
2.8 | 124.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
2.8 | 33.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
2.8 | 5.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
2.7 | 67.5 | PID FOXO PATHWAY | FoxO family signaling |
2.7 | 69.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.7 | 67.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
2.7 | 63.9 | PID RHOA PATHWAY | RhoA signaling pathway |
2.6 | 58.1 | PID ARF 3PATHWAY | Arf1 pathway |
2.6 | 67.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
2.6 | 90.1 | PID ALK1 PATHWAY | ALK1 signaling events |
2.6 | 238.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
2.4 | 7.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
2.3 | 23.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
2.2 | 18.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
2.2 | 6.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
2.1 | 31.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
2.0 | 55.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.8 | 60.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.8 | 118.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.8 | 93.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.8 | 38.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.8 | 62.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.8 | 8.9 | PID IGF1 PATHWAY | IGF1 pathway |
1.8 | 53.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.7 | 43.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.6 | 3.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.6 | 73.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.6 | 19.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.6 | 42.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.5 | 16.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.5 | 27.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.5 | 7.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.4 | 9.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.3 | 48.2 | PID CDC42 PATHWAY | CDC42 signaling events |
1.3 | 99.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.2 | 27.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.1 | 15.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.1 | 27.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.1 | 21.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.0 | 4.1 | PID IFNG PATHWAY | IFN-gamma pathway |
1.0 | 9.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.0 | 44.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.0 | 47.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.9 | 1.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.9 | 10.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.9 | 29.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.9 | 24.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 57.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.8 | 14.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.8 | 2.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.8 | 4.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 13.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 12.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.7 | 39.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 38.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.6 | 12.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.6 | 27.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.5 | 9.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 14.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.4 | 4.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 15.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 12.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 9.9 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 7.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 9.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 4.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 11.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 3.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 6.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 0.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 7.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.7 | 39.4 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
16.2 | 32.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
14.4 | 445.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
14.0 | 238.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
14.0 | 195.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
12.2 | 415.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
12.1 | 109.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
11.5 | 137.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
10.8 | 97.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
10.8 | 840.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
9.9 | 347.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
9.9 | 228.0 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
9.8 | 372.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
9.7 | 155.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
9.2 | 240.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
9.2 | 211.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
8.9 | 53.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
8.7 | 77.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
8.6 | 51.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
8.3 | 91.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
8.2 | 156.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
8.2 | 254.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
8.1 | 349.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
8.1 | 227.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
7.9 | 149.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
7.6 | 106.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
7.5 | 119.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
7.5 | 306.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
7.4 | 14.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
7.4 | 435.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
7.4 | 73.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
7.3 | 153.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
7.3 | 203.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
7.2 | 50.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
7.2 | 365.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
7.2 | 57.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
7.1 | 71.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
7.1 | 142.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
7.0 | 189.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
7.0 | 139.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
6.6 | 86.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
6.5 | 26.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
6.4 | 32.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
6.4 | 154.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
6.4 | 89.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
6.3 | 227.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
6.2 | 99.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
6.1 | 110.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
6.1 | 60.6 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
5.9 | 29.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
5.9 | 99.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
5.8 | 132.3 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
5.7 | 5.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
5.7 | 68.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
5.5 | 226.1 | REACTOME S PHASE | Genes involved in S Phase |
5.4 | 182.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
5.3 | 154.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
5.3 | 47.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
5.2 | 57.6 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
5.2 | 72.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
5.2 | 412.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
5.1 | 254.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
5.0 | 95.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
4.9 | 186.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
4.9 | 170.2 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
4.8 | 128.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
4.8 | 123.8 | REACTOME KINESINS | Genes involved in Kinesins |
4.6 | 46.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
4.5 | 139.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
4.3 | 34.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
4.3 | 97.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
4.2 | 167.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
4.0 | 127.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
4.0 | 107.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
4.0 | 71.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
3.9 | 86.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
3.9 | 3.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
3.9 | 92.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
3.8 | 219.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
3.8 | 73.0 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
3.8 | 68.3 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
3.8 | 53.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
3.7 | 25.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
3.7 | 851.1 | REACTOME TRANSLATION | Genes involved in Translation |
3.6 | 132.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
3.6 | 7.1 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
3.5 | 55.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
3.5 | 229.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
3.5 | 221.3 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
3.4 | 213.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
3.4 | 489.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
3.3 | 13.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
3.3 | 69.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
3.3 | 16.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
3.2 | 87.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.1 | 37.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
3.1 | 109.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
3.0 | 62.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
3.0 | 62.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
3.0 | 103.8 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
3.0 | 284.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
3.0 | 47.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
2.9 | 11.8 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
2.9 | 81.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
2.9 | 43.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
2.9 | 69.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
2.9 | 8.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
2.7 | 280.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
2.7 | 123.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
2.7 | 2.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
2.6 | 108.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
2.6 | 52.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
2.6 | 38.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
2.6 | 126.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
2.4 | 31.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.3 | 13.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
2.3 | 74.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
2.2 | 39.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.2 | 39.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
2.1 | 42.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
2.1 | 27.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.0 | 22.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.8 | 48.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.8 | 27.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.8 | 53.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.7 | 57.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
1.7 | 8.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.7 | 32.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.7 | 28.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
1.6 | 82.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.6 | 25.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.6 | 7.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.5 | 3.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
1.5 | 19.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.5 | 28.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.5 | 16.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.5 | 3.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.4 | 106.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.4 | 36.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.4 | 8.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.4 | 1.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
1.4 | 23.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.4 | 57.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.3 | 32.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.3 | 29.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
1.3 | 2.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.3 | 14.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
1.3 | 3.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.3 | 83.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.2 | 18.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.2 | 18.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.2 | 31.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.1 | 15.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.1 | 19.6 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
1.0 | 36.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
1.0 | 14.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.9 | 29.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.9 | 13.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.9 | 42.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 30.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.8 | 13.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.8 | 4.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.8 | 3.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.8 | 8.9 | REACTOME OPSINS | Genes involved in Opsins |
0.8 | 3.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 3.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.6 | 1.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.6 | 17.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 3.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.5 | 5.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.5 | 39.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.5 | 5.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 10.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 1.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.5 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 27.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 5.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.4 | 5.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 1.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.4 | 4.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 5.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.4 | 5.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 7.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 19.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 7.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 4.8 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 5.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 28.1 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.2 | 6.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 1.8 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 1.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |